curriculum vitae - University Institute of Immunology - Universität Bern

CURRICULUM VITAENameBeda Martin STADLERDate and June 21. 1950place of birthVisp, SwitzerlandCitizenshipSwitzerlandPrivate address Bubenbergplatz 4CH-3011 BernSwitzerlandtel. +41 31 312 7947mobile +41 79 460 5745E-mail. beda.stadler@bluewin.chWork addressInstitute of ImmunologyUniversity of BernInselspitalSahlihaus 2CH-3010 BernSwitzerlandtel. +41 31 632 35 21 / 20fax. +41 31 381 57 35E-mail. beda.stadler@iib.unibe.chMarital statusmarried with Heidi Stadler-Tanner2 children, Nina and Kornel

C.V.: Beda M. Stadler page 2ContentCURRICULUM VITAE ............................................................................................................ 1CONTENT ........................................................................................................................... 2EMPLOYMENT ...................................................................................................................... 4SPECIAL DUTIES .................................................................................................................. 5SOCIETIES .......................................................................................................................... 7AWARDS ............................................................................................................................ 8HONORS .......................................................................................................................... 10EDITORIAL BOARDS ............................................................................................................ 11BIBLIOGRAPHY .................................................................................................................. 12ORIGINAL CONTRIBUTIONS ................................................................................................... 12MONOGRAPHS AND REVIEWS ................................................................................................. 20BOOKS, EDITIONS AND TRANSLATIONS .................................................................................... 27PATENTS .......................................................................................................................... 28EDITORIALS, ESSAYS AND INTERVIEWS .................................................................................... 30ABSTRACTS ....................................................................................................................... 36

C.V.: Beda M. Stadler page 3EDUCATION1963 - 1971 College Spiritus Sanctus, Brig, Switzerland.1971 - 1975 University of Bern, SwitzerlandMajor: MicrobiologyI. Minor: ChemistryII. Minor: Medical Microbiology1975 - 1977 Licentiate in biology,Natural Sciences Faculty, University of Bern, Switzerland,Institute of Clinical Immunology and Allergology, Inselspital.1976 Training course in immunology, University of Tübingen, GER.1977 - 1979 Doctorate phil. nat. (PhD in molecular biology),Natural Sciences Faculty, University of Bern, Switzerland,Institute of Clinical Immunology and Allergology, Inselspital.1979 - 1981 Post doctoral training, National Institutes of Health (N.I.H.),National Institute of Dental Research, Laboratory ofMicrobiology and Immunology, (Dr. Joost J. Oppenheim),Bethesda, Maryland, USA.1979 Graduate school at N.I.H., Bethesda, USA.Tutorial seminars by Drs. R. Schwartz and A. Singer.1980 Graduate school at N.I.H., Bethesda, USA.Tutorial seminars organized by Dr. R. Friedman.1986 Habilitation (Venia Docendi), Private Docent,Medical Faculty, University of Bern, Switzerland.1991 FAMH: Specialist for clinical immunological analytics1991 Professor of immunology (n.a.aoP),Medical Faculty, University of Bern, Switzerland.2001 Ordinary Professor of immunologyMedical Faculty, University of Bern, Switzerland.

C.V.: Beda M. Stadler page 4Employment1977 - 1979 Research and teaching assistant, Institute of ClinicalImmunology and Allergology, University of Bern, Switzerland.1979 Laboratory assistant for graduate course in allergy andclinical immunology, Institute of Clinical Immunology andAllergology, University of Bern.1979 - 1981 Fogarty visiting fellow, N.I.H., National Instituteof Dental Research, Bethesda, USA.Sponsor: Dr. Joost J. Oppenheim1981 - 1991 Senior Staff Scientist,Institute of Clinical Immunology and Allergology, InselspitalUniversity of Bern.1982 - 1986 Lecturer (Oberassistent-Lektor),Institute of Clinical Immunology and Allergology, InselspitalUniversity of Bern.1986 - 1991 Private docent (Oberassistent-PD),Institute of Clinical Immunology and Allergology InselspitalUniversity of Bern.1991 - 1997 Director, Central Animal Facilities,Inselspital and University, Bern.1991 - 2001 Professor in immunology (n.a.aoP),Institute of Clinical Immunology and Allergology, University of Bern.Immunology teaching for medical students, PhD students, dentists,pharmacists, and medical laboratory technicians.1998 - 2001 Lecturer (Lehrbeauftragter) in immunology , University of Fribourg2000 - 2004 Lecturer (Lehrauftrag) Institut für Sport und Sportwissenschaft, University ofBern2001 - present Director Institute of Immunology, University of Bern,

C.V.: Beda M. Stadler page 5Special Duties1991 - 1992 Member, Supervisory Commission for Animal Research,Dept. of Health, Canton of Bern.1991 - 2005 National delegate, International Association of Allergy and ClinicalImmunology.1991 - 1999 Expert, Research Foundation 3R (Reduction, Refinement, Replacement ofanimal experimentation)1992 - 2002 Vice-president, Supervisory Commission for Animal Research, Dept. ofHealth, Canton of Bern.1992 - 1999 Member, international grant grants-in-aid subcommittee, American Academyof Allergy and Immunology.1992 - 2001 Board, European Cytokine Society1993 - 1998 Member, specialist commission for standardization of in vitro assays,European Academy of Allergy and Clinical Immunology.1994 - 1998 Member, specialist commission for recombinant allergens, EuropeanAcademy of Allergy and Clinical Immunology.1994 - present Member, Board of Foundation. GEN SUISSE.(http://www.gensuisse.ch/home/index.html)1995 - present Member, scientific commission, Pfizer Foundation-Research Prize.1996 - present Expert for medical analytics / clinical immunology, Swiss AccreditationService, Swiss Federal Office of Metrology, Federal Department of Justice andPolice, Switzerland.1996 - 1998 Member, forumGEN - Persönlichkeiten für eine sinnvolle Bio- undGentechnologie.1996 - present Member, Board of Foundation, FERAI (Foundation for Education and Researchin Allergy and Immunology), Switzerland.1997 - 2004 Member, Board of Advisory Commission, School of Medical Technicians,Inselspital, Bern, Switzerland.1997 - present Member, Scientific Advisory Board, Internutrition, Switzerland.(http://www.internutrition.ch/home/advisory.html)1998 - 2004 Member, Scientific Advisory Board, Berna Biotech, Switzerland.1998 - 2002 Member, Board of the Swiss Society of Allergology and Immunology,Switzerland.1998 - present Member of the Board, Wissenschaftlerkreis Grüne Gentechnik, Austria,Germany, and Switzerland.(http://www.bio-scope.com/experten.htm)

C.V.: Beda M. Stadler page 61999 - 2003 Member, Commission for Technology and Innovation (CTI, the InnovationPromotion Agency) of the Federal Office of Professional Formation andTechnology, Department of National Economic Affairs, Switzerland.1999 - present Member, commission «Grundstudium Medizinstudenten», Medical Faculty,University of Bern.1999 - present Member, commission «3. Studienjahr Medizinstudenten», Medical Faculty,University of Bern.1999 - present Member, «Wissenschafts Café», Medical Faculty, University of Bern.2000 - 2001 Coordinator, «INO Planung, Projektgruppe 5.1», Department DOLS,Inselspital, Bern.2000 - present Member, Ethics Commission for Animal Research, «Swiss Academy ofMedical Sciences and Swiss Academy of Natural Sciences», Basel.2001 - present Member, CTI Start up, Industrial Team, Commission for Technology andInnovation of the Federal Office of Professional Formation and Technology,Department of National Economic Affairs, Switzerland.2003 - present Head, Section Life sciences, Commission for Technology and Innovation(CTI, the Innovation Promotion Agency) of the Federal Office of ProfessionalFormation and Technology, Department of National Economic Affairs,Switzerland.2003 - 2006 Member, ISA Team, Initiative for Succsessful Ageing, Commission forTechnology and Innovation of the Federal Office of Professional Formationand Technology, Department of National Economic Affairs, Switzerland.2006 - present Member, board, Volkshochschule Bern.2008 - present Member, board, Giordano Bruno Stiftung (Stiftung zur Förderung desevolutionären Humanismus)

C.V.: Beda M. Stadler page 7SocietiesSwiss Society of Allergology and ImmunologyAmerican Association of ImmunologistsCollegium Internationale AllergologicumGerman Society of ImmunologyEuropean Academy of Allergology and Clinical ImmunologyUnion of the Swiss Societies of Experimental Biology

C.V.: Beda M. Stadler page 8Awards1979 - 1981 Graduate fellowship, Swiss National Fund for Scientific Research1979 - 1981 Visiting fellowship, Fogarty International Center, USA1982 - 1983 Research grant, Swiss National Fund for Scientific Research(Grant number 3.165-0.81)1983 - 1985 Research grant, Swiss National Fund for Scientific Research(Grant number 3.500-0.83)1985 - 1988 Research grant, Swiss National Fund for Scientific Research(Grant number 3.249-0.85)1988 - 1990 Research grant, Swiss National Fund for Scientific Research(Grant number 3.885-0.88)1990 - 1993 Research grant, Swiss National Fund for Scientific Research(Grant number 32-28660.90)1991 - 1994 Research grant, 3R Research Foundation1993 - 1995 Research grant, Swiss National Fund for Scientific Research(Grant number 31-36083.92)1995 - 1996 Research grant, Swiss Federal Veterinary Office(Grant number 014.95.6)1995 - 1998 Research grant, Swiss National Fund for Scientific Research(Grant number 31-41915.94)1995 - 1997 Research grant, BVET1996 - 1999 Research grant, Swiss National Fund for Scientific Research(Grant number 3100-045634.95)1996- 1999 NRP37 Research grant, Swiss National Fund for ScientificResearch (Grant number 4037-44804)1998 - 2001 Research grant, Swiss National Fund for Scientific Research(Grant number 3100-052469.97)1998 - 2001 Bundesministerium für Forschung und Technologie,(BMFT) Germany.Research and development grant awarded as a collaborative project with Dr.M. Ernst, Biotest AG and Prof. M. Little, DKFZ, Heidelberg.1999- 2001 NRP37 Research grant, (continuation) Swiss National Fund for ScientificResearch (Grant number 4037-44804)

C.V.: Beda M. Stadler page 92001 - 2003 Research grant, Swiss National Fund for Scientific Research(Prolongation of Grant number 3100-052469.97)2003 - 2006 Research grant, Swiss National Fund for Scientific Research(Grant number 3200B0-100651)2003 - 2006 Research grant, Commission for Technology and Innovation (CTI) of theFederal Office of Professional Formation and Technology, Department ofNational Economic Affairs, Switzerland.2007 - 2010 Research grant, , Commission for Technology and Innovation (CTI) of theFederal Office of Professional Formation and Technology, Department ofNational Economic Affairs, Switzerland.(Grant Number. 8803.1 LSPP-LS)

C.V.: Beda M. Stadler page 10Honors1982 Prize of the Austrian Society of Dermatologyfor the work on ETAF, together with Drs. T.A. Luger, J.J. Oppenheim and S.I.Katz.1991 Prize of the Pharmacia Allergy Research Foundation,Recipient of an honorable mention, for scientific progress in allergy research.1992 Plaque of the Korean Society of Allergology,for the lecture entitled "Immunoregulation in Allergy by Anti-IgEAutoantibodies". Annual autumn meeting.1992 Medal of the Yonsei University College of Medicine, Seoul,for lecturing at the graduate school, Departement of Medical Sciences, Seoul,Korea.1993 Honory Certificate of the Bohemian Medical Society,at the annual allergy and clinical immunology meeting in Prag.1995 Herbert Herxheimer Memorialprize. From the German Society of Allergy andImmunity Research (2nd prize) to: Stämpfli, M.R., Miescher, S., Aebischer, I.,Zürcher, A.W. and Stadler, B.M. for the paper: „Inhibition of human IgEsynthesis by anti-IgE antibodies requires divalent recognition“, published in Eur.J. Immunol. 24:2161-2167. 1994.1996 Preis für die beste Arbeit eines Medizinstudenten/ einer Medizinstudentin. Tagder klinischen Forschung, Bern, Pachlopnik JM, Stämpfli MR, Aebischer I,Rudolf MP, Miescher SM, Stadler BM. Antigen interaction and heat inactivationexpose new epitopes on human IgE.

C.V.: Beda M. Stadler page 11Editorial Boards1986 - 1991 LYMPHOKINE RESEARCHED. L.B. LACHMANNMary Ann Liebert, Inc. publishers,New York, USA1989 - present EUROPEAN CYTOKINE NETWORKEDS. JACQUES BERTOGLIO AND DIDIER FRADELIZIJohn Libbey, Eurotext-Editions, Medicine-Sciences,Montrouge, France1992 - 2002 EXPERIMENTAL DERMATOLOGYED. THOMAS A. LUGERPublisher: Munksgaard, Copenhagen, Denmark1992 - 1997 INTERNATIONAL ARCHIVES OF ALLERGYAND IMMUNOLOGYED. GEORG WICKVerlag S. Karger AG, Basel, Switzerland1997 - present INTERNATIONAL ARCHIVES OF ALLERGYAND IMMUNOLOGYED. DIETRICH KRAFTVerlag S. Karger AG, Basel, Switzerland1997 - present ALLERGY & CLINICAL IMMUNOLOGY INTERNATIONALED. ALAIN L. DE WECKHogrefe & Huber Publishers, Göttingen, Germany

C.V.: Beda M. Stadler page 12BIBLIOGRAPHYOriginal Contributions1. Stadler, B.M., and de Weck, A.L. Cytofluorometric analysis of macrophages activated in vivo or in vitro. Eur.J. Immunol. 8:243-246. 19782. Nakagawa, T., Stadler, B.M., and de Weck, A.L. Determination of rat mast cells by flow-cytometry. J.Immunol. Meth. 33:87-92. 19803. Stadler, B.M., and de Weck, A.L. Flow - cytometric analysis of mouse peritoneal macrophages. Cell.Immunol. 54: 36-48. 19804. Stadler, B.M., Spengler, H., and de Weck, A.L. Flow-cytometric determination of active and total rosettes. J.Immunol. Meth. 35: 201-211. 19805. Stadler, B.M., Kristensen, F., and de Weck, A.L. Thymocyte activation by cytokines: Direct assessment ofG0-G1 transition by flow-cytometry. Cell. Immunol. 55: 436-443. 19806. Stadler, B.M., Farrar, J.J., Oppenheim, J.J. Cell cycle dependent production of interleukin 2. Behring Inst.Mitt. 67: 245-248. 19807. Farrar, J.J., Fuller-Farrar, J.J., Simon, D.L., Hilfiker, M.L., Stadler, B.M., and Farrar, W.L. Thymomaproduction of T cell growth factor (interleukin 2). J. Immunol. 125: 2555-2558. 19808. Nakagawa, T., Stadler, B.M., and de Weck, A.L. Flow-cytometric analysis of human basophil degranulation. I.Quantification of human basophils and their degranulation by flow-cytometry. Allergy. 36: 39-47. 19819. Nakagawa, T., Stadler, B.M., Heiner, D.C., Skvaril, F., and de Weck, A.L.Flow-cytometric analysis of humanbasophil degranulation. II. Degranulation induced by anti-IgE, anti-IgG4 and the calcium ionophore A23287.Clinical Allergy. 11: 21-30. 198110. Stadler, B.M., Dougherty, S.F., Farrar, J.J., and Oppenheim, J.J. Relationship of cell cycle to recovery of IL-2activity from human mononuclear cells, human and mouse T cell lines. J. Immunol. 127: 1936-1940. 198111. Luger, T.A., Stadler, B.M., Katz, S.I., and Oppenheim, J.J. Epidermal cell (keratinocyte) derived thymocyteactivating factor (ETAF). J. Immunol. 127: 1493-1498. 198112. Farrar, J., Paetkau, V., Fuller-Farrar, J., Moore, R.N., Hilfiker, M.L., Stadler, B.M., and Farrar, W.L. Mouseand human T cell line derived interleukin 2. Lymphokines. 5: 353-370. 198213. Lin, Y., Stadler, B.M. and Rabin, H. Synthesis of biologically active interleukin 2 by Xenopus oocytes inresponse to Poly(A)-RNA from a gibbon T cell line. J. Biol. Chem. 257: 1587-1590.198214. Stadler, B.M., and Oppenheim, J.J. Human interleukin 2: Biological studies using purified IL-2 andmonoclonal anti IL-2 antibodies. Lymphokines. 6: 117-135. 198215. Stadler, B.M., Berenstein, E.H., Siraganian, R.P., and Oppenheim, J.J. Monoclonal antibodies against humaninterleukin 2 (IL-2). I. Purification of IL-2 for the production of monoclonal antibodies. J. Immunol. 128: 1620-1624. 1982

C.V.: Beda M. Stadler page 1316. Luger, T.A., Stadler, B.M., Luger, B.M., Mathieson, J., Mage, M., Schmidt, J.A., and Oppenheim, J.J. MurineEpidermal cell derived thymocyte-activating factor resembles murine interleukin 1. J. Immunol. 128: 2147-2152. 198217. Timonen, T., Ortaldo, J., Stadler, B.M., Bonnard, G.D., Sharrow, S. and Herberman, R.B. Cultures of humannatural killer cells: growth in the presence of interleukin 2. Cell. Immunol. 72: 178-185. 198218. Meuer, S.C., Hussey, R.E., Penta, A.C., Fitzgerald, K.A., Stadler, B.M., Schlossman, S.F., Reinherz, E.L.Cellular restricted IL-2 production by T4+ and T8+ T lymphocytes. J. Immunol. 129: 1076-1079. 198219. Domzig, W., Stadler, B.M., and Herberman, R.B. Interleukin 2 dependence of natural killer (NK) cell activity.J. Immunol. 130: 1970-1973. 198320. Luger, T.A., Stadler, B.M., Luger, B.M., Sztein, M.B., Schmidt, J.A., Hawley-Helson, P., and Oppenheim, J.J.Characteristics of an epidermal cell thymocyte activating factor produced by human keratinocytes and ahuman squamous cell carcinoma cell line. J. Invest. Dermatol. 81: 187-193. 198321. Meyer, C., Wahl, L.M., Stadler, B.M., and Siraganian, R.P. Cell cycle associated changes in histaminerelease from rat basophil leukemia cells separated by counterflow centrifugal elutriation. J. Immunol. 131:911-914. 198322. Tadokoro, K., Stadler, B.M., and de Weck, A.L. Factor dependent in vitro growth of human normal bonemarrow-derived basophil-like cells. J. Exp. Med. 158: 857-871. 198323. Wahl, S.M., Katona, I.M., Stadler, B.M., Wilder, R.L., Helsel, W.E., and Wahl, L.M. Isolation of humanmononuclear cell subsets by counterflow centrifugal elutriation (CEE). II. Functional properties of Blymphocyte T lymphocyte and monocyte enriched fractions. Cell. Immunol. 85: 384-395. 198424. Wang, Y., Walker, C., Stadler, B.M., and de Weck, A.L. Transcription and translation dependent induction ofInterleukin 2 (IL-2) and IL-2 receptors. Immunol. Lett. 8: 227-231. 198425. Evêquoz, V., Bettens, F., Kristensen, F., Trechsel, U., Stadler, B.M., Dayer, J.-M., de Weck, A.L., andFleisch, H. Interleukin 2-independent stimulation of rabbit chondrocyte collagenase and prostaglandin Eproduction by an interleukin 1 like factor. Eur. J. Immunol. 14: 490-495. 198426. Hodler, B., Evêquoz, V., Trechsel, U., Fleisch, H., and Stadler, B.M. Influence of vitamin D3 metabolites onthe production of interleukin 1, 2 and 3. Immunobiology. 170: 256-269. 198527. Yu, H., Tadokoro, K., Stadler, B.M., and de Weck, A.L. Inhibitory effect of histamine on Interleukin 2production. Chinese J. of Microbiology and Immunology. 5: 201-206. 198528. Hong, C.S., Stadler, B.M., Wälti, M., and de Weck, A.L. Dot immunobinding assay with monoclonal anti IgEantibodies for the detection and quantitation of human IgE. J. Immunol. Methods. 95: 195-202. 198629. Kings, M.A., Conroy, M.C., Stadler, B.M., Magnusson, C.G.M., Skvaril, F., and de Weck, A.L. Histaminerelease from human leukocytes by anti-IgE antibodies: influence of multiple or single epitope recognition.Diagn. Immunol. 4: 89-96. 198630. Grassi, J., Didierlaurent, A., and Stadler, B.M. Quantitative determination of total and specific human IgEusing monoclonal antibodies. J. of Allergy and Clinical Immunology. 77: 808-822. 198631. Mazingue, Ch., Stadler, B.M., Quatannens, B., Capron, A., and de Weck, A.L. Schistosome derived inhibitoryfactor: an immunosuppressive agent preferentially active on T cells. Int. Arch. Allergy Appl. Immunol. 80:347-354. 198632. Knutti-Müller, J., Stadler, B.M., Magnusson, C.M., and de Weck, A.L. Human IgE synthesis in vitro: Detectionwith monoclonal antibodies. Allergy. 41: 457-467. 198633. Köck, A., Danner, M., Stadler, B.M., and Luger, T.A. Characterization of a monoclonal antibody directedagainst the biologically active site of human interleukin 1. J. Exp. Med. 163: 463-468. 1986

C.V.: Beda M. Stadler page 1434. Walker, C., Kristensen, F., Bitter-Suermann, D., Stadler, B.M., and de Weck, A.L. Interference of a C3fragment preparation with IL-2 dependent proliferation. J. Immunol. 136: 3396-3401. 198635. Tanno, Y., Stadler, B.M., and Denburg, J.A. Human interleukin-3 like activity, basophil and eosinophil growthpromoting activities and colony stimulating factor derived from several cell lines. Int. Arch. Allergy Appl.Immunol. 83: 1-5. 198736. Mazingue, Ch., Walker, Ch., Domzig, W., Capron, A., de Weck, A.L., Stadler, B.M. Effect of schistosomederived inhibitory factor on the cell cycle of T lymphocytes. Int. Arch. of Allergy and Appl. Immunol. 83: 12-18. 198737. Gauchat, J.-F., Walker, Ch., de Weck, A.L., and Stadler, B.M. Relation of supernatant IL-2 to steady statelevels of IL-2 mRNA. Lymphokine Res. 5: 43-47. 198638. Yang, X.-D., de Weck, A.L., and Stadler,B.M. Induction of human in vitro IgE synthesis via stimulation byanti-CD3 antibody. Eur. J. Immunol. 18: 467-471. 198839. Hirai, K., de Weck, A.L., and Stadler,B.M. Characterization of a human basophil-like cell promoting activity. J.Immunol. 140: 221-227. 198840. Gauchat, J.-F., Walker, Ch., de Weck, A.L., and Stadler, B.M. Stimulation dependent lymphokine mRNAlevels in human mononuclear cells. Eur. J. Immunol. 18: 1441-1446. 198841. Sandru, G., Veraguth, P., and Stadler, B.M. Stimulation of tumor cell growth in humans by a mononuclearcell- derived factor. Cancer Res. 48: 5411-5416. 198842. Pichler, W.J., Schindler, L., Stäubli, M., Stadler, B.M., and de Weck, A.L. Anti-amiodarone antibodies:detection and relationship to the development of side effects. Am. J. Med. 85: 197-202. 198843. Tadokoro, K., Stadler, B.M., and de Weck, A.L. Further biochemical characterization of human basophil-likecell promoting activity and its distinction from human interleukin-3 like activity. Int. arch. Allergy appl.Immunol. 86:162-169. 198844. Qiu, G., Gauchat, J-F., Wirthmüller, U., de Weck, A.L., and Stadler B.M. Lymphokine production by humanperipheral blood lymphocytes: Analysis by in situ hybridization. Lymphokine Res. 7: 385-392. 198845. Felix, R., Elford, P.R., Stoercklé, C., Cecchini, M., Wetterwald, A., Trechsel, U., Fleisch, H., and Stadler,B.M. Production of hemopoietic growth factors by bone tissue and bone cells in culture. J. Bone. Miner. Res.3: 27-36. 198846. Yang, X.-D., de Weck, A.L., and Stadler, B.M. Effect of recombinant human Interleukin 4 on spontaneous invitro human IgE synthesis. Eur. J. Immunol. 18: 1699-1704. 198847. Gauchat, J.-F., de Weck, A.L., and Stadler, B.M. Decreased cytokine mRNA levels in the elderly. Aging(Immunology and Infectious Disease) 1 :191-204. 198948. Gauchat, J.-F., Gauchat, D., de Weck, A.L., and Stadler, B.M. Cytokine mRNA levels in antigen stimulatedperipheral blood mononuclear cells. Eur. J. Immunol. 19: 1079-1085. 198949. Brantschen, S., de Weck, A.L., and Stadler, B.M. Factors influencing proliferation and histamine content ofcultured human bone marrow cells. Immunobiol. 179: 271-282. 198950. Nakajima, K., de Weck, A.L. and Stadler, B.M. Effect of anti-IgE antibodies on IgE binding to CD23. Allergy44: 187-191. 198951. Daxun, Z., and Stadler B.M. A dot immunobinding assay for penicillin specific antibodies: Allergic diagnosisand prediction. Asian Pac. J. Allergy Immunol. 7: 23-28. 198952. Brantschen, S., Gauchat, J.-F., de Weck, A.L., and Stadler, B.M. Differential expression of cytokine RNAs inhuman cell lines. Lymphokine Research. 8: 163-171. 1989

C.V.: Beda M. Stadler page 1553. Brantschen, S., Gauchat, J.-F., de Weck, A.L., and Stadler, B.M. Regulatory effect of recombinant IL-3 andIL-4 on cytokine gene expression of bone marrow and peripheral blood mononuclear cells. Eur. J. Immunol.19:2017-2023. 198954. Zhu-D-X, Stadler-B-M. (In vitro diagnosis of penicillin allergy by dot immunobinding assay). Chung-Hua-I-Hsueh-Tsa-Chih. 69 (7): 396-398, 198955. Gauchat, D., Gauchat, J.-F., Bettens, F., de Weck, A.L., and Stadler, B.M. Cytokine gene expression inatopics: Effect of IL-4 on IL-1 beta and IL-6 mRNA levels. Eur. Cytokine Network. Vol. 1: 85-90. 199056. Vassella, C.C., de Weck, A.L. and Stadler, B.M. Natural anti-IgE antibodies interfere with diagnostic IgEdetermination. Clin. Exp. Allergy. 20: 295-303. 199057. Jarolim, E., Poulsen, L.K., Stadler, B.M., Mosbech, H., Osterballe, O., Kraft, D. and Weeke B. A long termfollow-up study after hyposensitization using immunoblotting. J. Allergy Clin. Immunol. 85: 996-1004. 199058. Walker, C., Gauchat, J.-F., de Weck, A.L., and Stadler, B.M. Analysis of leukocyte markers in elderlyindividuals. Aging (Immunology and Infectious Disease) 2: 31-44. 199059. Morita, Y., Hirai, K., Misaki, Y., Takaishi, T., Susuki, S., Ito, K., Stadler, B.M., and Miyamoto T. Enhancementof basophil histamine release by human basophil-like cell promoting activity. Allergy. 45: 183-188. 199060. Loidolt, D., Vassella, C.C., de Weck, A.L. and Stadler, B.M. Die klinische Bedeutung von anti IgE Antikörpernfür die Behandlung der allergischen Rhinopathie. Laringorhinootolologie. 69: 255-259. 199061. Qiu, G., Vogel, M., Gauchat, J-F., Mandallaz M., de Weck, A.L., and Stadler, B.M. Human IgE mRNAexpression by peripheral blood lymphocytes stimulated with Interleukin 4 and Pokeweed Mitogen. Eur. J.Immunol. 20: 2191-2199. 199062. Jensen-Jarolim, E., Vogel, M., de Weck, A.L. and Stadler, B.M. Anti-IgE antibodies mistaken for specific IgE.J. Allergy and Clin. Immunology 89:31-43, 199063. Ritter, C., Bättig, M., Kraemer, R. and Stadler, B.M. IgE hidden in immune complexes with anti-IgEautoantibodies in children with asthma. J. Allergy and Clin. Immunology 88:793-801, 199164. Vassella, C.C., de Weck, A.L. and Stadler, B.M. Influence of IgE on IgE determination. Int. Arch. Allergy.Appl. Immunol. 92:272-280, 199165. Fuchs, M., Stadler, B.M., Malinverni, R., de Weck, A.L., Pichler, W.J. Zusammenhang zwischen T-Subpopulationen und Klinik von HIV-assoziierten Krankheiten. Schweiz. Med. Wschr. 121:57-66, 199166. Wyss, M., Scheitlin, T., Stadler, B.M., Wüthrich, B. Immunotherapy with aluminum hydroxide adsorbed insectvenom extracts (Alutard SQ): immunologic and clinical results of a prospective study over 3 years. Allergy.48: 81-6. 199367. de Weck, A.L., Stadler, B.M., Urwyler, A., Wehner, H.U., and Bühlmann, R.P. Cellular Allergen StimulationTest (CAST) - A new dimension in allergy diagnosis. Allergy and Clinical Immunology News 5: 9-14. 199368. de Weck, A.L., Derer, M., Stadler, B.M., Bättig, M., Hunziker, U,. Hess, S. and Seger, R. Simple and RapidDetermination of Cord Blood IgE and IgE Complexes. Allergy and Clinical Immunology News 5: 52-58.199369. Vogel, M., Miescher, S., Biaggi, C. and Stadler, B.M. Human anti-IgE Antibodies by Repertoire Cloning. Eur.J. Immunol.24:1200-1207 199370. Kraemer, R., Wirz-Sommer, C. Gschwend-Eigenmann, S., Schöni, M.H. and Stadler, B.M. Interfering factorsto sensitivity and specificity of bronchial reactivity in children. Pediatr. Allergy Immunol. 4: 187-195. 199371. Miescher, S., Vogel, M., Stämpfli, M.R., Wasserbauer, E., Kricek, F., Vorburger, S. and Stadler B. M.,Domain specific anti-IgE antibodies interfere with binding to FcRII. Int. Archives of Allergy andImmunology. 105:75-82. 1994.

C.V.: Beda M. Stadler page 1789. Escher, R., Muller, D., Vogel, M., Miescher, S., Stadler, B.M. and Berchtold, P. Recombinant human naturalautoantibodies against GPIIb/IIIa inhibit binding of autoantibodies from patients with AITP. Br. J. Haematol.102: 820-828. 199890. Pachlopnik, J.M., Stämpfli, M.R., Rudolf, M.P., Aebischer, I., Kricek, F., Miescher, S. and Stadler, B.M.Antigen Interaction and Heat Inactivation Expose New Epitopes on Human IgE. Int. Arch. Allergy Immunol.117: 231-238. 199891. Miescher, S., Vogel, M., Biaggi, C., Ramseyer, V., Hustinx, H., Eicher, N., Imboden, M.A., Spycher, M.O.,Amstutz, H. and Stadler, B.M. Sequence and specificity analysis of recombinant human fab anti-Rh Disolated by phage display. Vox. Sang. 75: 278-287. 199892. Jensen-Jarolim E. Leitner A., Kalchhauser H, Zürcher A., Gangelberger E., Bohle B., Scheiner O., Boltz-Nitulescu G., Breiteneder H. peptide mimotopes displayed by phage inhibit antibody binding to Bet v 1, themajor birch pollen allergen, and induce specific IgG response in mice. The FASEB Journal. 12: 1635-1642.199893. Millauer, N., Zürcher, A.W., Miescher, S.M., Gerber, H.A., Seitz, M., Stadler, B.M., High IgE in rheumatoidarthritis (RA) patients is complexed with anti-IgE autoantibodies. Clin. Exp. Immunol. 115: 183-188. 1999.94. Horn, M.P., Gerster, T., Ochensberger, B., Derer, T., Kricek, F., Jouvin, M.-H., Kinet, J.-P., Vogel, M.,Stadler, B.M. and Miescher, S.M. Anti-FcRI alpha auto-Abs in healthy individuals donors cross react withtetanus toxoid. Eur. J. Immunol 29: 1139-1148. 1999.95. Jensen-Jarolim, E., Wiedermann, U., Ganglberger, E., Zürcher A., Stadler, B.M., Boltz-Nitulescu, G.,Scheiner, O., Breiteneder. H. Allergen mimotopes in food enhance type I allergic reactions in mice. TheFASEB Journal. 13: 1586-1592. 1999.96. Thurnheer M.C., Zürcher A.W., Miescher S.M., Rudolf M.P., Vogel M., Stadler B.M. Molecular mimicry of theunidentified antigen of myeloma antibody IgE-ND. Eur. J. Immunol. 29, No. 9, 2676-2683. 199997. Nechansky, A., Ruf, C., Pursch, E., Wasserbauer, E., Stämpfli, M., Pachlopnik, J.M., Stadler, B.M. andKricek, F., Interaction of human IgE with Fcepsilon RI alpha exposes hidden epitopes on IgE. Int. Arch.Allergy and Immunology 120: 295-302. 1999.98. Zürcher A.W., Miescher S.M., Vogel M., Rudolf M.P., Stadler M.B., Stadler B.M. Oral anti-immunoglobulin Eimmunization with epitope-displaying phage. Eur. J. Immunol., 30, No. 1, 128-135. 2000.99. Vogel, M., Miescher, S., Kuhn, S., Zürcher, A.W., Stadler, M.B., Ruf, C., Effenberger, F., Kricek, F. andStadler, B.M. Mimicry of human IgE epitopes by anti-idiotypic antibodies. J Mol Biol, 298: 729-735, 2000100. Rudolf, M.P., Zürcher, A.W., Nechansky, A., Ruf, C., Vogel, M., Miescher, S.M., Stadler, B.M. and Kricek, F.Molecular basis for non-anaphylactogenicity of a monoclonal anti-IgE antibody. J. Immunol. 15;165(2):813-9.2000101. Miescher, S., Zahn. M., De Jesus. M., Moudry. R., Fisch. I., Vogel, M., Imboden. M., Stadler, B.M., Mermod.N., Amstutz H.-P., and Wurm. F. CHO expression of a novel human recombinant IgG1 anti-RhD antibodyisolated by phage display. British Journal of Haematology. 111(1):157-66. 2000102. Horn, M. P., Pachlopnik, J. M., Vogel M., Dahinden M., Wurm, F., Stadler, B. M. and Miescher S. M.Conditional Autoimmunity Mediated by Human Natural Anti-FcRI Autoantibodies?. The FASEB Journal.15:2268-2274, 2001.103. Miescher. S. M., Horn M. P., Pachlopnik, J. M., Baldi, L., Vogel, M., Stadler, B. M.. Natural anti-FcRIautoantibodies isolated from healthy donors and chronic idiopathic urticaria patients reveal a restrictedrepertoire and autoreactivity on human basophils. Human Antibodies and Hybridomas 10(3-4):119-26.2001.

C.V.: Beda M. Stadler page 18104. Stadler BM, Miescher S, Horn M, Pachlopnik J, Stadler M, Kricek F, Vogel M. Allergic manifestations as theresults of a conditional autoimmune response. Int Arch Allergy Immunol. 124(1-3): 411-3. 2001105. Escher R, Vogel M, Escher G, Miescher S, Stadler BM, Berchtold P. Recombinant anti-idiotypic antibodiesinhibit human natural anti-glycoprotein (GP)IIb/IIIa autoantibodies. J Autoimmun. 18(1): 71-81. 2002106. Marina Hugot, Nicolas Bensel, Monique Vogel, Martine T. Reymond, Beda Stadler, Jean-Louis Reymond,and Ulrich Baumann. A structural basis for the activity of retro-Diels-Alder catalytic antibodies: Evidence for acatalytic aromatic residue. PNAS 99: 9674-9678. 2002.107. Scheppler L, Vogel M, Zuercher AW, Zuercher M, Germond JE, Miescher SM, Stadler BM. RecombinantLactobacillus johnsonii as a mucosal vaccine delivery vehicle. Vaccine. 20(23-24): 2913-20. 2002108. Finger AN, Bisoffi M, Wetterwald A, Gautschi E, Hohenfeld U, Klima I, Stadler BM, Mazzucchelli L, ThalmannGN, Cecchini MG. Scavenger receptor block as strategy for the identification of bone marrow homing phagesby panning in vivo random peptide phage displayed libraries. J Immunol Methods. 264(1-2): 173-86. 2002109. M. B. Stadler and B. M. Stadler. Allergenicity prediction by protein sequence. The FASEB Journal. Journalexpress article 10.1096/fj.02-1052fje. Published online April 22, 2003, and 17:1141-1143. 2003110. Jana M. Pachlopnik, Michael P. Horn, Michaela Fux, Markus Dahinden, Michèle Mandallaz, DominiqueSchneeberger, Lucia Baldi, Monique Vogel, Beda M. Stadler, and Sylvia M. Miescher. Natural Anti-FcRIAutoantibodies may Interfere with Diagnostic Tests for Autoimmune Urticaria. J. Autoimmunity. 22(1): 43-51, 2004111. Vogel M, Tschopp C, Bobrzynski T, Fux M, Stadler MB, Miescher SM, Stadler BM. A highly conservedinterspecies V(H) in the human genome, J. Mol Biol. 6;341(2):477-89. 2004112. Miescher SM, Schaub A, Ghielmetti M, Baumann M, Vogel M, Bolli R, Stadler B. Comparative analysis ofantigen specificities in the monomeric and dimeric fractions of intravenous immunoglobulin. Ann N Y AcadSci. 1051:582-90. 2005113. Scheppler, L., Vogel, M., Marti, P., Müller, L., Miescher, S.M. and Stadler.B.M. Intranasal immunisation usingrecombinantn Lactobacillus johnsonii as a new strategy to prevent allergic disease. Vaccine 23:1126-34,2005.114. Fux, M., Vogel, M., Stadler, M.B., Stadler B.M. and Miescher, S.M. Detection of one V H antibody sequence inboth healthy donors and urticaria patients. J Immunol Methods. 307(1-2):107-17. 2005115. Bobrzynski, T., Fux, M., Vogel. M., Stadler, B.M. and Miescher, S.M. A high affinity natural autoantibody fromhuman cord blood defines a physiologically relevant epitope on the FcRI. J Immunol, 175: 6589-6596.2005116. Michael B. Stadler *, Diana Arnold, Sara Frieden, Sarah Luginbühl, Beda M. Stadler. Single nucleotidepolymorphisms as a prerequisite for autoantigens. European Journal of Immunology. 35: 371 – 378. 2005117. Hantusch B, Knittelfelder R, Wallmann J, Krieger S, Szalai K, Untersmayr E, Vogel M, Stadler BM, ScheinerO, Boltz-Nitulescu G, Jensen-Jarolim E. Internal images: Human anti-idiotypic Fab antibodies mimic the IgEepitopes of grass pollen allergen Phl p 5a. Mol Immunol. 2006 Jul;43(14):2180-7. Epub 2006 Feb 28.118. Stephan von Gunten, Alexander Schaub, Monique Vogel, Beda M. Stadler, Sylvia Miescher, and Hans-UweSimon. Immunologic and functional evidence for anti–Siglec-9 autoantibodies in intravenous immunoglobulinpreparations. BLOOD, 108(13): 4255-4259. 2006119. P Marti, R Truffer, MB Stadler, E Keller-Gautschi, R Crameri, A Mari, P Schmid-Grendelmeier, SM Miescher,BM Stadler, M Vogel: Allergen motifs and the prediction of allergenicity. Immunol Lett. 109, (1), 15 47-552007.

C.V.: Beda M. Stadler page 19120. ALEXANDER SCHAUB, SANDRA WYMANN, MANFRED HELLER,b MARCO GHIELMETTI, ZSUZSANNEBELEZNAY, BEDA M. STADLER, REINHARD BOLLI, AND SYLVIA MIESCHER, Self-Reactivity in theDimeric Intravenous Immunoglobulin Fraction Ann. N.Y. Acad. Sci. 1110: 681–693 2007.

C.V.: Beda M. Stadler page 20Monographs and ReviewsR-1.R-2.R-3.R-4.R-5.R-6.R-7.Stadler, B.M., Dougherty, S.F., Carter, C., Berenstein, E.H., Fox, P.C., Siraganian, R.P., and Oppenheim,J.J. Monoclonal antibodies against the interleukins. in: Lymphokines and Thymic Hormones: PotentialUtilization in Cancer Therapeutics. Raven Press, N.Y. eds. A.L. Goldstein and M.A. Chirigos 66-76. 1981.Stadler, B.M., Berenstein, E.H., Siraganian, R.P., and Oppenheim, J.J. Monoclonal antibody against humaninterleukin 2 (IL-2). in: Mechanism of Lymphocyte Activation. Elsevier/N. Holland, Amsterdam. eds. H.Kirchner and K. Resch 570-572. 1981.Herberman, R.B., Brunda, M.J., Djeu, J.Y., Domzig, W., Goldgarb, R.H., Holden, T., Ortaldo, J.R., Reynolds,C.W., Riccardi, C., Santoni, A., Stadler, B.M., and Timonen, T. Immunoregulation and natural killer cells.Human Cancer Immunology, Natural Killer Cells. Elsevier Biomedical Press, Amsterdam.4: 37-52. 1981.Oppenheim, J.J., Stadler, B.M, Siraganian, R.P., Mage, M., and Mathieson, B. Lymphokines: their role inlymphocyte responses. Properties of interleukin 1. Fed. Proc. 41: 257-262. 1982Domzig, W., and Stadler, B.M. The relationship between human natural killer cells and interleukin 2. in: NKcells and other natural effector cells. Acad. Press, ed. R.B. Herberman.409-414 1982Reinhardt, M.C., Stadler, B.M., and de Weck, A.L. Lymphokines, Monokines et Cytokines: Médiateurs demessages intercellulaires. Arch. Fr. Pédiatr. 39: 559-563. 1982Stadler, B.M., Liechti, J., and Bonnard, G.D. T cell stimulating lectings are mitogen inducers but notmitogens. in: Lectins: Biology, Biochemistry, Clinical Biochemistry. De Gruyter, Berlin. eds. Bog Hansenand G.A. Spengler. 3: 37-45. 1982R-8. Liechti, J., Stadler, B.M., and de Weck, A.L. Correlation between resistance markers and interleukin 2production of the T cell line HSB-2. Proceedings of the III. International Lymphokine Workshop.Academic Press, eds. S. Cohen, J.J. Oppenheim. 3: 634-640. 1983R-9.R-10.R-11.R-12.R-13.R-14.R-15.Tadokoro, K., Stadler, B.M., and de Weck, A.L. Factor dependent growth of normal bone marrow-derivedhuman basophils with histamine-releasing activity. Proceedings of the III. International LymphokineWorkshop. Academic Press, eds. S. Cohen, J.J. Oppenheim. 3: 131-138. 1983Stadler, B.M., Knutti-Müller, J.M., Tadokoro, K., Bettens, F., Yu, H., Brantschen, S., Wang, S., and de Weck,A.L. Potential role of interleukins in immunological dysregulation syndromes. Immunopharm. Raven Press,ed. P.A. Miescher. 23: 59-65. 1984Stadler, B.M., and de Weck, A.L. Role of lymphokines in immediate type allergy. Lymphokines. SpringerSeminars in Immunopathology. 7: 415-424. 1984de Weck, A.L., Stadler, B.M., Knutti-Müller, J., Ruff, P., Hofstetter, H., Lüdin, C., and Heusser, C. Factorsinfluencing human IgE synthesis in vitro and in vivo. Int. Arch. Allergy appl. Immunol. 77: 38-44. 1985Stadler, B.M., Hirai, K., Tadokoro, K., and de Weck, A.L. Distinction of the human basophil promoting activityfrom human interleukin 3. Int. Arch. Allergy appl. Immun. 77: 151-154. 1985Stadler, B.M., Hirai, K., Tadokoro, K., and de Weck, A.L. Distinction of the human basophil promoting activityfrom a human IL-3 like factor. in: Cellular and Molecular Biology of Lymphokines. Academic Press, eds.C. Sorg and A. Schimpl. 479-483. 1985Stadler, B.M., Hirai, K., Schaffner, T., and de Weck, A.L.A growth factor for human mast cells. in: Mast celldifferentiation and heterogeneity. Raven Press, eds. A.D. Befus, J. Bienenstock and J.A. Denburg. 159-165. 1985.

C.V.: Beda M. Stadler page 21R-16.R-17.R-18.R-19.R-20.R-21.R-22.R-23.R-24.R-25.R-26.R-27.R-28.R-29.Stadler, B. M., Knutti-Mueller, J. M., Tadokoro, K., Bettens, F., Yu, H., Brantschen, S., Wang, Y., and deWeck, A. L. Potential role of interleukins in immunological dysregulation syndromes. Serono Symp. Publ.Raven Press. 23 (Immuno-pharmacology) 59-65 1985de Weck, a.L., Stadler, B.M., Mazingue, Ch., Walker, Ch., and Bettens, F. Modulation of T cell activation bylymphokines and other biologically active compounds. in: Recent advances in primary and acquiredimmunodeficiency. Raven Press, eds. F. Aiuti, F. Rosen and M.D. Rosen. Serono Symposia Publications.28: 75-81. 1986Stadler, B.M., and de Weck, A.L. The role of lymphokines and cytokines in allergic reactions. in:Proceedings XIII Congress of the European Academy of Allergology and Clinical Immunology. AlföldiNyomda. eds. B. Csaba, A. Leövey, P. Szemere. 193-202. 1986.Stadler, B.M., Müller, J.M., Tadokoro, K., Bettens, F., Yu, H.-J., Brantschen, S., Wang, Ya-xing, and deWeck, A.L. Interleukins and immunological dysregulation syndromes. J. Luzhou Medical College 9: 215-218. 1986de Weck, A.L., Stadler, B.M, Kristensen, F., Bettens, F., Joncourt, F., and Walker, C. Interleukin 2 and otherimmunoregulatory T cell lymphokines: biological significance. in: IUPHAR 9th International Congress ofPharmacology London 1984, Proceedings. The Macmillan Press Ltd. eds. William Paton, James Mitchell,Paul Turner. 3: 295-300. 1984Köck, A., Danner, M., Luger, T.A., Stadler,B.M. Characterization of a monoclonal anti human IL-1 antibody.in: Cellular and Molecular Biology of Lymphokines. Academic Press, eds. C. Sorg, A. Schimpl. 357-362.1985Guerin, B., Didierlaurent, A., Derer, M., Stadler, B.M. Seuil de positivité - interprétation des résultats duRAST. Rev. Fr. Allergol. 25: 189-195. 1985de Weck, A.L., Stadler, B.M., Knutti-Müller, J. Regulation of IgE synthesis by lymphoid-cell derived factors.in: New Trends in Allergy. Springer Verlag, Berlin - Heidelberg, eds. J. Ring and G. Burg. 16-24. 1986Stadler, B.M., Hirai, K., Hildbrand, M.-L., Yang, X., Kings, M., and de Weck, A.L. Lymphokines and cytokinesin immediate type allergic reactions. in: Proceedings of the XII Intern. Congr. of Allergol. and Clin.Immunol. The C.V. Mosby Company. 290-293. 1986de Weck, A. L., Stadler, B.M., Mazingue, C., Walker, C., and Bettens, F. Modulation of T cell activation bylymphokines and other biologically active compounds. Serono Symp. Publ. Raven Press 28 (Recent Adv.Primary Acquired Immunodefic.) 75-81.1986Stadler, B.M., Hirai, K., Brantschen, S., and de Weck, A.L. Biological and biochemical characteristics of thebasophil-like cell promoting activity (BaPA) and a human IL 3-like activity. Immunobiology 172: 225-230.1986Stadler, B.M., Gauchat, D., Hildbrand, M.-L., Yang, X., and de Weck, A.L. Human T-hybridoma derivedimmunoglobulin binding factors. Int. Arch. Allergy appl. Immunol. 82: 405-407. 1987Stadler, B.M., Hirai, K., Brantschen, S., Nakajima, K., and de Weck, A.L. Biochemical characterization of thehuman basophil promoting activity (BaPA). Int. Arch. Allergy appl. Immunol. 82: 338-340. 1987Stadler, B.M., et Gauchat, D. Concepts nouveaux de l'immuno-régulation et leur signification pour l'allergie.(Current concepts in immunoregulation and its significance for allergies). Rev. Méd. Suisse Romande 107:289-293. 1987R-30. Stadler, B.M. Lymphokine - ihre Bedeutung für das Immunsystem. Der informierte Arzt 17: 22-27. 1987R-31. Stadler, B.M. Lymphokine in der Therapie. Der informierte Arzt 18: 13-16. 1987

C.V.: Beda M. Stadler page 22R-32.R-33.R-34.Stadler,B.M., Brantschen, S., Hirai, K., Nakajima, K., Walz, A., and de Weck, A.L. Growth and differentiationfactors for human metachromatically staining cells. in: Molecular Basis of Lymphokine Action. The HumanPress, Inc. eds. D.R. Webb, C.W. Pierce, and St. Cohen. 409-418. 1987Stadler, B.M. From lymphokines to allergy. in: From Allergy to Immunology. Hans Huber Publishers,Toronto, Lewiston NY., Stuttgart, Bern. eds. Stadler, B.M., Schneider, C.H., Pichler, W.J., and Dahinden,C.A. 140-143. 1988Stadler, B.M., and Hirai, K. Human growth factors for metachromatically staining cells. in: Pan SpecificHemopoietic Growth Factors, Lymphokines. Academic Press, ed. J.W. Schrader. 15: 341-354. 1988R-35. Reinhardt, M., and Stadler, B.M. Immunologie des Gastrointestinaltraktes. in: InterdisziplinäreGastroenterologie: "Gastroenterolgoische Pathophysiologie". Springer Verlag Heidelberg, eds. H.R. Koelzund P. Aeberhard. 27-40. 1987R-36.R-37.R-38.R-39.R-40.R-41.R-42.R-43.R-44.R-45.Stadler, B.M., Hirai, K. and Gauchat J-F. Production and measurement of interleukin 2 and 3. in: ThePharmacology of Lymphocytes, Handbook of Experimental Pharmacology. Springer Verlag Heidelberg.eds. J. Morley and M.A. Bray. 85: 235-253. 1988Stadler, B.M., Vassella, C., Gauchat, J.-F., Walker, C., and de Weck, A.L. Influence of drugs on lymphokinegene expression. in: Toxicological and Immunological Aspects of Drug Metabolism and EnvironmentalChemicals Symposia Medica Hoechst. F.K. Schattauer Verlag. eds. R.W, Estabrook, E. Lindenlaub, F.Oesch and A.L. de Weck. 22: 297-305. 1988Fagg, B., Hirai, K., Nakajima, K., and Stadler B.M. Human recombinant IL-3 promotes the growth of humanbasophils/mast cells. in: Mechanisms of action and therapeutic applications of biologicals in cancer andimmune deficiency disorders. UCLA Symposia on molecular and cellular biology. eds. Groopman, J.,Evans, C., and Golde, D. Allan R. Liss, Inc. New York, NY. 100: 1988Stadler, B.M., Nakajima, K., Yang, X., and de Weck, A.L. Potential role of anti-IgE antibodies in vivo. Prog.Int. Arch. Allergy Appl. Immunol. 88: 206-208. 1989Stadler, B.M., Gauchat, J-F., Gang, Q., Gauchat, D., Yang, X., Brantschen, S., Vassella, C. and de Weck,A.L. Cytokine regulatory circuits. Topics in Immunolgy: 9th European Immunology Meetin Papers. F.,Aiuti, L., Bonomo, G., Danilli. Roma: il Pensiero scientifico Editore. 1989Stadler, B.M., Gauchat, J-F., Nakajima, K., Gauchat, D., Vassella, C., Brantschen, S., Gang, Q., Yang, X.,Mandallaz, M., and de Weck, A.L. Lymphocytes and Lymphokines in immediate type hypersensitivity. in:Progress in Allergy and Clinical Immunology. Proceedings of the 13th international congress ofallergology and clinical immunology. Hogrefe & Huber Publishers. Toronto, Lewiston NY, Bern, Göttingen,Stuttgart. eds. W.J. Pichler, B.M. Stadler, C. Dahinden, A.R. Pecoud, P.C. Frei, C. Schneider and A.L. deWeck. 18-21. 1989Pichler, W.J., Schindler, L., Stäubli, M., Stadler, B.M., and de Weck, A.L. Detection of anti-Amiodaronantibodies in patients with side effects. in: Toxicological and immunological aspects of drug metabolism andenvironmental chemicals. Symposia Medica Hoechst. F.K. Schattauer Verlag. eds. R.W, Estabrook, E.Lindenlaub, F. Oesch and A.L. de Weck.. 22: 453-471, 1989Stadler, B.M., Gauchat, D., Vassella, C., Nakajima, K., Gang, Qiu., Gauchat, J.-F. Anti-Isotype Regulation:Cytokines and Anti-IgE Autoantibodies. in: Cytokines Regulating the Allergic Response. ed. C. Sorg,Cytokines. Karger, Basel., 2: 37-50. 1989de Weck, A.L., Stadler, B.M., Dahinden, C.A. New perspectives in the modulation of allergic inflammation.Int. Arch. Allergy. Appl. Immunol. 90: 17-21.1989de Weck, A.L., Stadler, B.M., Dahinden, C.A. Neue Perspektiven in der Modulation der allergischenEntzündung. (New aspects in the modulation of allergic inflammation). Zeitschrift für Hautkrankheiten. 65:12-16. 1990

C.V.: Beda M. Stadler page 23R-46.R-47.R-48.Stadler, B.M., Gang, Qiu., Vassella, C., Loidolt, D., Jarolim, E., Vogel, M., and de Weck, A.L. IgE anti-IgEund Lymphokine bei allergischen Krankheiten. Allergologie 9:322-324, 1990Gang, Qiu. and Stadler, B.M., Human IgE mRNA expression by peripheral blood lymphocytes stimulated withinterleukin 4 and pokeweed mitogen. Cytokines: Basic Principles and Clinical Applications. SeronoSymposia Publications from Raven Press. 68: 277-279. 1990Jarolim, E., and., Stadler, B.M. Anti-IgE autoantibodies hide specific IgE and are mistaken for specific IgG. in:New Trends in Allergy III. Springer Verlag, Berlin-Heidelberg, ed. J. Ring. pp. 112-114, 1991R-49. Vogel, M., and., Stadler, B.M. Immunorégulation chez les atopiques Médecine et Hygiène 1852: 2311-2313.1990R-50.R-51.R-52.R-53.R-54.R-55.R-56.R-57.R-58.R-59.R-60.R-61.R-62.Stadler, B.M., Jarolim, E., Vogel, M., Miescher, S., Aebischer, I., and Gang, Qiu. The role of anti-IgEautoantibodies in allergic Inflammation. in: Clinical Impact of the Monitoring of the Allergic Inflammation.Academic Press Ltd, London. eds. P. Matson, S. Ahlstedt, P. Venge and J. Thorell. pp. 59-70, 1991Jensen-Jarolim, E., de Weck, A.L. and., Stadler, B.M. Are allergen specific IgG mainly IgG anti-IgEautoantibodies. Int. Arch. Allergy and Appl. Immunol. 94:102-103, 1991Stadler, B.M., Gang, Qiu. Vogel, M., Jarolim, E., Miescher, S., Aebischer, I., and de Weck A.L. IgG anti-IgEautoantibodies in immunomodulation. in: Cellular and Molecular Networks in Clinical Immunology andAllergy. Int. Arch. Allergy. Appl. Immunol. Karger Verlag. 94:83-86, 1991Gauchat, J-F,. Gauchat, D., Gang, Qiu. Mandallaz, M. and Stadler, B.M. Detection of cytokine mRNA inpolyclonally-, antigen- or allergen- stimulated mononuclear cells. Immunological Reviews. Munksgaard,Copenhagen. 119:147-161, 1991Stadler, B.M., Vogel, M., Aebischer, I., Miescher, S., Stämpfli, M.R., von Mühlenen I., Vorburger, S., andGang Qiu. IgE and anti-IgE antibodies: Key elements in the allergic response. in: Highlights in Allergy andClinical Immunology. Hogrefe & Huber Publisher. ed. B. Wüthrich. pp. 35-38, 1991Stadler, B.M., Vogel, M., Miescher, S., Aebischer, I., Stämpfli, M.R., Furukawa, K., Holzner, M.E., Yu Yan,and Qiu Gang. Immunoregulation by anti-immunoglobulin E autoantibodies. in: Advances in Allergologyand Clinical Immunology. ed. Ph. Godard, J. Bousquet, F.B. Michel. The Parthenon Publishing Group. pp.3-8, 1992Stadler, B.M., Miescher, S., Vogel, M., Furukawa, K., Aebischer, I., Stämpfli, M.R., Holzner, M.E., Yu Yan,Qiu Gang. Anti-IgE autoantibodies: A functional comparison with heterologous antibodies. in: Progress inAllergy and Clinical Immunology. Hogrefe and Huber Publishers, 2:182-185, 1992Stadler, B.M. Anti-IgE Autoantibodies: A possible specific feedback on the cytokine network in allergy?European Cytokine Network. 3: 437-441 1992Stadler, B.M. New Trends in Allergy. in: Progress in Immunology VIII. ed: J. Gergely et al., SpringerHungarica, Berlin. pp. 395-402, 1992Stadler, B.M. Bedeutung von IgE-haltigen Immunkomplexen. in: Med-Report. Blackwell WissenschaftsverlagGmbH, Berlin. p. 2, 1993Stadler, B.M., Stämpfli, M., Vogel, M., Aebischer, I., Furukawa, K., Holzner, M.E., Rudolf, M.P., Miescher, S.,A specific feed-back by anti-IgE autoantibodies on the cytokine network in allergy. in: Update on ChildhoodAsthma. eds M.H. Schöni and R. Kraemer. Agents and Actions Supplements. 40:144-152, 1993De Weck, A.L., and Stadler, B.M. Good and bad IgE and anti-IgE antibodies: New Molecular Concepts. in:Molecular Biology and Immunology of Allergens. CRC Press. eds D. Kraft and A. Sehon. pp. 101-111.1993Stadler, B.M., Stämpfli, M., Miescher, S., Furukawa, K., Vogel, M. Biological activities of anti-IgE Antibodies.Int. Arch. Allergy. Immunol. 102:121-126, 1993

C.V.: Beda M. Stadler page 24R-63.R-64.R-65.R-66.R-67.R-68.R-69.R-70.R-71.Stadler, B.M. Immunoglobulin E Regulation - Beyond the Cytokine Network. Allergy and ClinicalImmunology News 5:160-162. 1993Miescher, S., Vogel, M., Stämpfli M.R. and Stadler, B.M. Not all Anti-IgE are the same - Opposing Effects ofAnti-IgE Antibodies on IgE Binding to FcRII Correlates with their Epsilon Domain Specificity. Allergy andClinical Immunology News 5:163-164. 1993Stämpfli, M.R., Miescher S. and Stadler, B.M. Control of Human IgE Synthesis by Anti-IgE Antibody. Allergyand Clinical Immunology News 5:165-166. 1993de Weck, A.L. and Stadler, B. Good or bad IgE and anti-IgE antibodies: New molecular concepts. Ed. Kraft,D. and Sehon, A.H. Boca Raton, Fla. - CRC. Conference Proceeding. Mol. Biol. Immunol. Allergens 101-111. 1993Vogel, M., Miescher, S., Biaggi, C. and Stadler, B.M. Finding the Needle in the Hay Stack - Isolation ofHuman anti-IgE Antibodies by Repertoire Cloning Allergy and Clinical Immunology News 5:167-169. 1993Aebischer, I., Stämpfli, M.R., Zürcher, A., Miescher, S., White R.R. and Stadler, B.M. IgE Synthesis and theBrain. Allergy and Clinical Immunology News 5:169-170. 1993de Weck, A.L., Derer, M., Morrison-Smith, G., Braquemond, P., Stadler, B.M. and Guérin B. Deétectionquantitative d’IgE totales et d’IgE spécifiques par bandelettes Immunodot: une nouvelle technologie pour ledépistage des maladies allergiques. Rev. Française d’Allergologie et d’Immunol. Clin. 33:13-21. 1993Stadler, B. M., Vogel, M., Miescher, S.and Stämpfli, M. R. Anti-IgE antibodies as immunomodulators. AllergoJ. 3:148-153. 1994.Stadler, B.M. Anti-IgE Autoantibodies in Asthma: A Diagnostic Artefact or an Explanation for non-allergicAsthma? Revue Méd. Suisse Romand. 114: 1994R-72. Stadler, B.M. Autoimmune and endocrine regulation of the Allergic response Allergie et Immunologie. 26:(4)122-124. 1994R-73.R-74.R-75.R-76.R-77.R-78.R-79.Stadler, B.M. Herstellung von humanen monoklonalen Antikörpern in vitro durch Repertoir Klonierung. In:Ersatz- und Ergänzungsmethoden zu Tierversuchen: . eds. Schöffel H. Spielmann H. and Tritthart H.A.Forschung ohne Tierversuche 1995 . Schöffel H. Spielmann H., Tritthart H.A.., Gussler, K., Fuhrmann, U.,Goetschel, A.F., Gruber, F.P., Heusser, C., Möller, H., Ronneberger, H. and Vedani, A. Springer Verlag,Wien, New York. 301-306. 1995Stadler, B.M., Stämpfli, M., Miescher, S., Vogel, M. Cloning of human anti-IgE Autoantibodies and their rolein Regulation of IgE synthesis. Int. Arch. Allergy. Immunol. 107: 48-50. 1995Stadler, B.M. Neuroendocrine and autoimmune regulation of the allergic response in: Regulatory Controland Standardization of Allergenic Extracts. Eds: R. Kurth and D. Hauenstein. Gustav Fischer Verlag,Stuttgart, Jena, New York. 87:293-299. 1994Stadler, B.M., Gang, Qiu., Vassella, C., Loidolt, D., Jarolim, E., Vogel, M., and de Weck, A.L. IgE anti-IgEund Lymphokine bei allergischen Krankheiten. Hautnah Dermatologie 11: 616-617, 1995Szczeklik, A., Jawien, J., Stadler, B.M., Radwan, J., Piworaska, W., and Dziatkowiak, A. Possible relationshipbetween interleukin-6 and response of immunoglobuline E to surgical trauma. In: Interleukin-6 type cytokines.Annals of the New York Academy of Science. 762: 477-479, 1995Stadler, B.M. Psycho-neuroendocrine factors and IgE regulation, in Kongressband, 49. Van SwietenKongress, ed. M.P. Dierich, Verlag der Österreichischen Ärztekammer, Wien. 424-428. 1995Vogel, M. and Stadler, B.M. Human recombinant antibodies. Der Tierschutz-beauftragte, Thomas DennerVerlag & Medien Service, München. ISSN-No 0942-4229. 3: 250-251. 1995

C.V.: Beda M. Stadler page 25R-80.R-81.R-82.R-83.R-84.R-85.Aebischer, I. and Stadler, B.M. Th1-TH2 cells in allergic responses: at the limits of a concept. Advances inImmunology. 61: 341-403. 1996Stadler, B.M., Vogel, M., Rudolf, M.P., Lilin Lai Zhang and Miescher, S., From recombinant to syntheticmimotopes, in: Proceedings of the European Peptide Society Meeting, Peptides in Immunology, ed. C.H.Schneider, John Wiley and Sons, Ltd. London. 31-37. 1996Stadler, B.M., Rudolf, M.P., Zürcher, A.W., Miescher, S., and Vogel, M. Anti-IgE in allergic inflammation.Immunology and Cell Biology. 74: 195-200. 1996Stadler, B.M. Neuroendocrine and autoimmune regulation of the allergic response in: Immunodeficiencyand allergy perspectives for immunomodulation and immunostimulation. Ed: MC. Reinhardt. ISBN 2-9700123-0-8. Foundation for Education and Research in Allergy and Immunology. 1:75-86. 1996Stadler, B.M., Stämpfli, M., Vogel, M., Rudolf, M.P., Zürcher, A.W., and Miescher, S. Natural andrecombinant anti-IgE autoantibodies. New horizons in allergy immunotherapy. In: Advances inExperimental Medicine and Biology. Eds. A. Sehon, K.T. HayGlass, and D. Kraft. Plenum Press, New York.411-416. 1996Stadler, B.M., Rudolf, M.P., Vogel, M. Miescher, S., Zürcher, A.W., and F. Kricek. Can actice Immunizationredirect an anti-IgE response. Int. Arch. Allergy Immunol. (1-3): 216-218. 1997R-86. Stadler, B.M. Allergie. in: Immunologie. Grundlagen, Klinik, Praxis. 4. Auflage. Thieme Verlag. eds. D.Gemsa , J.R. Kalden, K. Resch. pp. 235-250, 1997R-87.R-88.Stadler, B.M. Clinical Aspects of Allergenicity. in: Proceedings of the International Symposium on NovelFoods Regulation in the European Union. Integrity of the Process of Safety Evaluation. bggv. pp. 279-285,1998de Weck, A.L. Derer, M. Morrison-Smith, G. Stadler, B.M. and Walliser M. Dustscreen, a New Assay forSimultaneous Determination of Multiple Allergens in House Dust, Allergy & Clinical ImmunologyInternational. VOL. 10, NO. 5. 1998R-89. Stadler, B.M. Mehr Allergien durch Gentechnik? Umweltmedizin in Forschung und Praxis. 3: 323-327.1998. (http://www.ecomed.ch/journals/ufp/themen/allergie.htm)R-90.Stadler, B.M., Zürcher, A.W., Miescher, S.M., Kricek, F., Vogel, M. Mimotope and anti-idiotypic vaccines toinduce an anti-IgE response. Int. Arch. Allergy Immunol. 118:119-121. 1999R-91. Stadler, B.M., Rudolf, M.P., M., Vogel, Miescher, S., and Zürcher, A.W. Regulation of Immunoglobulin E.Inflammation: anti-Immunoglobulin E autoantibodies. Immuno-therapy in asthma. In: Lung Biology in healthand disease. Eds. J. Bousquet, and H. Yssel. Marcel Dekker, New York Basel. 431-438. 1999R-92.R-93.R-94.R-95.Stadler, B.M., Vogel, M., and Miescher, S. Recombinant antibodies by phage display: The end of animal use?In: Progress in the Reduction, Refinement and Replacement of Animal Experimentation. Eds. M. Balls,A.-M. van Zeller and M.E. Halder. Elsevier Science B.V. Development in Animal and Veterinary Sciences.Vol. 31: 873-878. 2000Stadler, B.M. and Reinhard. M,. Résumé d’immunologie ou l’immunologie en 2 heures. Revue Médicale dela Suisse Romande.120: 595-607. 2000Stadler, B.M., S.M. Miescher, M.P. Horn, J.M. Pachlopnik, M.B. Stadler, F. Kricek, M. Vogel. Allergicmanifestations as the results of a conditional autoimmune response? Int. Arch. Allergy Immunol. 124(1-3):411-3. 2001.Stadler, B.M. Nicht jedes Protein ist ein Allergen. Nahrungsmittelallergien was gibt es neues? In: ModerneErnährung heute. Ed. Reinhard Matissek. Kompendium wissenschaftelicher Pressedienst 4: 75-81 2001.

C.V.: Beda M. Stadler page 26R-96.R-97.Horn, M.P., Lacroix-Desmazes, S., Stahle, D., Miescher, S.M., Stadler, B.M., Kazatchkine, M.D., Kaveri S.V.,Natural autoantibodies – benefits of recognizing “self” Mod. Asp. Immunobiol.Mod. Asp. Immunobiol. 1:267-270. 2001.Stadler BM; Miescher S; Horn M; Pachlopnik J; Stadler M; Kricek F; Vogel M Allergic manifestations as theresults of a conditional autoimmune response. Int Arch Allergy Immunol Jan-Mar;124(1-3):411-3 2001R-98. Stadler, B.M., Anti-IgE: ein ideales Rezept für Allergien? Ärztliche Praxis Dermatologie. Seite 32-33. 5Sept-Okt 2001R-99.R-100.R-101.R-102.R-103.Stadler BM, Pachlopnik J, Vogel M, Horn M, Dahinden M, Miescher S. Conditional autoantibodies in urticariapatients: a unifying hypothesis. J Investig Dermatol Symp Proc. 6(2): 150-2. 2001Beda M. Stadler, Renato Truffer, Lorenz Müller, Monique Vogel. Wieviele Allergene gibt es eigentlich?.Allergologie für die Praxis., Ed. W.Jorde. Dustri Verlag Dr. Karl Feistle. Seite 6-12. 2005.Beda M. Stadler, Michael B. Stadler, Lorenz Müller, Renato Truffer, Adriano Mari, Sylvia Miescher, MoniqueVogel. Autoimmunity and allergy; a bioinformatic approach. From Genes to Phenotypes - The Basis of FutureAllergy Management. Proceedings of the 25th Symposium of the Collegium Internationale Allergologicum.Løwenstein, H. / Bienenstock, J.B. / Ring, J. (Ed.) Allergy Clin Immunol Int. J. World Allergy Org., Hogrefe& Huber Publishers. Supplement 2. 32-36 2005.Aalberse RC, Stadler BM. In silico predictability of allergenicity: From amino acid sequence via 3-D structureto allergenicity. Mol. Nutr. Food Res. 50, 625-627. 2006Lochman I., Lochmanova A., Hamilton R.G., Stadler B.M.: Human IgE-Specific Autoantibodies andAutoantibodies to IgE Receptors. In Autoantibodies, Shoenfeld Y., Gershwin M.E., Meroni P.L. edit., SecondEdition, Elsevier, Amsterodam-Boston-Heidelberg-London-New York-Oxford-Paris-San Diego-San Francisco-Singapore-Sydney-Tokyo, pp.85-91. ISBN 10: 0-444-52763-X, ISBN 13: 978-0-444-52763-9. 2006

C.V.: Beda M. Stadler page 27Books, Editions and TranslationsE-1.From allergy to Immunology. Anniversary Symposium in Honour of Professor Alain de Weck. Hans HuberPublishers. Toronto, Lewiston N.Y., Bern, Stuttgart. eds. B.M. STADLER, C.H. SCHNEIDER, W.J. PICHLER, ANDC. DAHINDEN. 1-152. 1988E-2.Progress in Allergy and Clinical Immunology. Proceedings of the 13th International Congress ofAllergology and Clinical Immunology. Hogrefe & Huber Publishers. Toronto, Lewiston N.Y., Bern, Göttingen,Stuttgart. eds. W.J. PICHLER, B.M. STADLER, C. DAHINDEN, A.R. PECOUD, P.C. FREI, C. SCHNEIDER AND A.L. DEWECK. 1-579. 1989E-3.Allergie. in: Immunologie, Grundlagen-Klinik-Praxis 3. Auflage. Thieme Verlag, Stuttgart New York.STADLER, B.M., AND DE WECK, A.L. eds. D. Gemsa , J.R. Kalden, K. Resch. pp. 216-231, 1991E-4.Immunologie. Translation from „Cellular and Molecular Immunology“, A.K. Abbas, A.H. Lichtman und JordanS. Pober, second edition, by B.M. STADLER AND M. W. HESS. Verlag Hans Huber. Bern, Göttingen, Toronto,Seattle. 1-536, 1996E-5.Allergie. in: Immunologie, Grundlagen-Klinik-Praxis 4. Auflage. Thieme Verlag, Stuttgart New York.STADLER, B.M. eds. D. Gemsa , J.R. Kalden, K. Resch. ISBN 3135348040.http://www.thieme.de/fachaerzte/3135348040.html. pp. 235-250, 1997E-6.Es gibt keine menschlichen Gene. Mythen und Fakten über Gentechnologie. BEDA M. STADLER. VerlagHans Huber, Bern, Göttingen, Toronto, Seattle. ISBN 3-456-82911-6. 243 Pages, 1997E-7.Gene an die Gabel, das erste GVO Kochbuch der Welt. BEDA M. STADLER. Internutrion Zürichhttp://www.internutrition.ch, 1. Auflage. Burson Marsteller und Beda Stadler. 109 Seiten. August 2001

C.V.: Beda M. Stadler page 28PatentsP-1.Kricek F., Stadler B.M., Rudolf M., Ruf. Immunogene Peptidmimotope zur Herstellung einer Vakzine für dieTherapie und Prophylaxe allergischer Erkrankungen. Erfindungsmeldung SW632. SandozForschungszentrum Wien. 5. 12. 1995.P-2.Miescher S., Stadler, B.M. Vogel.M. Morell A. Polypeptides capable of forming antigen binding structures withspecificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use.European Patent 96810421.6-2116. Rotkreuzstiftung Zentrallaboratorium Blutspendedienst SRK, Bern. 24.6. 1996.P-3.Kricek; Franz (Biedermannsdorf, AT); Stadler; Beda (Bern, CH) Title: Peptide immunogens for vaccinationagainst and treatment of allergy United States Patent: 6,610,297 Issued: August 26, 2003 Inventors:Assignee: Novartis AG (Basel, CH) Appl. No.: 125641 Filed: August 21, 1998 PCT Filed: February 28,1997 PCT NO: PCT/EP97/01013 PCT PUB.NO.: WO97/31948 PCT PUB. Date: September 4, 1997P-4.KRICEK FRANZ (AT); STADLER BEDA (CH) PEPTIDE IMMUNOGENS FOR VACCINATION AGAINSTAND TREATMENT OF ALLERGY Patent number: SI885244T Publication date: 2003-06-30 Applicant:NOVARTIS AG (CH) Classification: - international: C07K16/00; A61K39/395 - european: Applicationnumber: SI19970030490T 19970228 Priority number(s): WO1997EP01013 19970228; EP1997090513619970228; GB19960004412 19960301; GB19960017702 19960822P-5.KRICEK FRANZ (AT); STADLER BEDA (CH). PEPTIDE IMMUNOGENS FOR VACCINATION AGAINSTAND TREATMENT OF ALLERGY Patent number: CA2245497 Publication date: 1997-09-04 Applicant:NOVARTIS AG (CH) Classification: - international: C07K19/00; C07K16/00; C07K17/00; A61K39/385;C07K16/42; A61K39/44 - european: Application number: CA19972245497 19970228 Priority number(s):WO1997EP01013 19970228; GB19960004412 19960301; GB19960017702 19960822P-6.Miescher S., Vogel.M. Stadler, B.M. Morell A, Imboden Martin, Amstutz Hanspeter. Polypeptides capable offorming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and theprocess for their preparation and use. World Patent (PCT) 97/49809. Rotkreuzstiftung ZentrallaboratoriumBlutspendedienst SRK, Bern. 31. 12. 1997.P-7.AMSTUTZ HANSPETER (KR); VOGEL MONIQUE (KR); IMBODEN MARTIN (KR); MIESCHER SYLVIA(KR); MORELL ANDREAS (KR); STADLER BEDA (KR) POLYPEPTIDES CAPABLE OF FORMINGANTIGEN BINDING STRUCTURES WITH SPECIFICITY FOR THE RHESUS D ANTIGENS, THE DNAENCODING THEM AND THE PROCESS. Patent number: KR2000022530 Publication date: 2000-04-25Applicant: ROTKREUZSTIFTUNG ZENTRALLAB Classification: - international: C12N15/13; C12N15/62;C07K16/34 - european: Application number: KR19980710975T 19981224 Priority number(s):EP19960810421 19960624(Also published as: WO9749809 (A1) TR9802692T (T2) RU2204602 (C2) AU722127 (B2))P-8.AMSTUTZ HANSPETER (CH); VOGEL MONIQUE (CH); IMBODEN MARTIN (CH); MIESCHER SYLVIA(CH); MORELL ANDREAS (CH); STADLER BEDA (CH). POLYPEPTIDES CAPABLE OF FORMINGANTIGEN BINDING STRUCTURES WITH SPECIFICITY FOR THE RHESUS D ANTIGENS, THE DNAENCODING THEM AND THE PROCESS. Patent number: EP0920509 Publication date: 1999-06-09 Inventor:AMSTUTZ HANSPETER (CH); VOGEL MONIQUE (CH); IMBODEN MARTIN (CH); MIESCHER SYLVIA(CH); MORELL ANDREAS (CH); STADLER BEDA (CH) Applicant: ROTKREUZSTIFTUNG ZENTRALLAB

C.V.: Beda M. Stadler page 29(CH) Classification: - international: C12N15/13; C12N15/62; C07K16/34; A61K39/395; G01N33/80 -european: Application number: EP19970929244 19970620 Priority number(s): EP19970929244 19970620;WO1997EP03253 19970620; EP19960810421 19960624P-9. Kricek F., Stadler B.M., Vogel, M. Recombinant Anti-Idiotypic Antibodies. Foreign filing specification -Case 4-30888/NFI 9925. Novartis Forschungsinstitut (NFI), Vienna. 12. 4. 2000.P-10.Stadler B.M., Vogel, M, Germond J.-E. and Fritsche R. Lactic acid bacteria as agents for treating andpreventing allergy. European Patent 01105138.0-2106 Société des Produits Nestlé S.A. Date of filing 02.03.2001. Patent Number: EP1239032. Publication date: 2002-09-11. Applicant(s): NESTLE SA (CH). RequestedPatent: Application Number: EP20010105138 20010302. Priority Number(s): EP20010105138 20010302 IPCClassification: C12N1/20; A61K39/395; A61P37/08; C07K16/42 EC Classification: C07K16/00;A23K1/00C2B; A23K1/18N; C07K16/42M10P-11.VOGEL MONIQUE; KRICEK FRANZ; STADLER BEDA Anti-idiotypic antibodies against antibodies whichinhibit the binding of immunoglobuline to its high affinity receptor. Patent number: ZA200107906 Publicationdate: 2003-06-26 Applicant: NOVARTIS AG Classification: - international: A61K; A61P; C07K; G01N -european: Application number: ZA20010007906 20010926 Priority number(s): GB19990008533 19990414(Also published as: WO0063252 (A1) EP1169353 (A1) US2002141989 (A1) TR200102877T (T2))P-12.KRICEK FRANZ (AT); STADLER BEDA (CH). PEPTID-IMMUNOGENE ZUR SCHUTZIMPFUNG GEGENUND BEHANDLUNG VON ALLERGIEN. Patent number: AT230417T Publication date: 2003-01-15 Applicant:NOVARTIS ERFIND VERWALT GMBH (AT) Classification: - international: C07K16/00; A61K39/395 -european: Application number: AT19970905136T 19970228 Priority number(s): WO1997EP0101319970228; GB19960004412 19960301; GB19960017702 19960822

C.V.: Beda M. Stadler page 30Editorials, Essays and InterviewsI-1.I-2.I-3.Stadler, B.M. Anti-IgE Antibodies. in: Conversations in Allergy II. Madeira, Portugal, ed. The UCBInstitute of Allergy. pp. 11-12, 1990.Koerffy, A., Vercelli, D., Zubler, R.H., Stadler, B.M., Moqbel, R., Rochat, T., Loutan, L., and Polla, B.S.Asthme, Allergie, Actualités: IgE, atopie et parasites. Revue Medicale de la Suisse Romande. 112: 879-884, 1992Stadler, B.M. Commentaire sur "Auto-anticorps liberateurs d'histamine dans l'urticaire chronique". deC.H.E. Grattan. Ann. Dermatol. Venereol. 119: 799. 1992I-4. Stadler, B.M. The Role of Anti-IgE Antibodies. Allergy and Clinical Immunology News. 4(5): 157. 1992I-5.I-6.I-7.I-8.I-9.Stadler, B.M. Notbremse gegen IgE-Überschuss. in: Münchner Medizinische Wochenschrift. MMVMedizin Verlag, München, 135(20): 68. 1993Leung, D.Y.M., Moqbel, R., Polla, B.S., Stadler, B., Vercelli, D., Zubler, R.. IgE, atopie et parasites. in:Asthme et Allergie. Médecine et Hygiène, Genève. eds. B.S. Polla and Dusser D. pp. 17-33. 1993Wenger B. (Stadler B.M.). Biotechnologie / Neueste Verfahren zur gentech-nologischen Herstellung vonMedikamenten: Machen was machbar ist. Der Bund, Thu. 23. June, 145:144, p9. 1994Hug W.C. (Stadler B.M.). Cover Story. Genforschung und Risikoevaluation: Keine Frage der Ethik.Schweizer Versicherung und Schweizerischer Versicherungskurier, Handelszeitung. Verlag, Küsnacht.5:4-7. 1994Stadler, B.M. and R.Greber. Human recombinant antibodies. 3R-Info-Bulletin ed by Foundation Research3R, Münsingen, Switzerland. 5. (Aug.). (http://www.forschung3r.ch/de/publications/bu5.html) 1995I-10. Stadler, B.M. als BaZ Gast: Es fehlen Informationszentren für Biotechnologie. Basler Zeitung, Nr.289, 11.Dez. 1995I-11. Stadler, B.M. Die Zentralen Tierställe der Medizinischen Fakultät. Inselbote, 4: 31-35 1995I-12.I-13.I-14.I-15.I-16.Stadler, B.M. Gibt es Allergierisiken bei Gentechnik-Nahrung? Zwische Prognosen Behauptungen undErfahrungswerten. (http://www.nzz.ch/online/02_dossiers/gentech/gen960717_stadler.htm) Neue ZürcherZeitung, 125: 15 1996.Stadler, B.M. Transgene Tiere und die Zukunft der medizinischen Forschung in der Schweiz [Transgenicanimals and the future of medical research in Switzerland]. Schweizerische MedizinischeWochenschrift, 126: 1775-1778, 1996Stadler, B.M. und Köchli, F. Interview durch Geiser, S. und Zuber, T. Erbstreit: Schöpfung undGentechnologie. Kirchenbote 17. Ed. Reformierter Pfarrverein Kanton Zürich. 82: 5-7 1996Stadler, B.M. Gentechnisch veränderte Lebensmittel sind sicherer! Für die Gentechnik in derNahrungsmittelindustrie. ARS MEDICI,19: 1165-1167, 1996.Stadler, B.M. Maus mit Ohr auf dem Rücken. Aktuelles, Stellungnahmen. Gen Suisse Homepage.(http://www.gensuisse.ch/act/maus.html), 1997I-17. Stadler, B.M. Pascal Schmidt. Ist Gentech-Food sicherer?. Thurgauer Zeitung,19. 2 1997.I-18. Stadler, B.M. Papaya, Kiwi und GVO: Wie gross ist Ihr Allergierisiko?. Gen-Dialog Allergien, 4/1997:

C.V.: Beda M. Stadler page 31I-19. Stadler, B.M. Allergierisiken bei Gentechnik-Nahrung. Schweizerische Apothekerzeitung Zeitung, 135:Nr. 7, 167-168 1997I-20. Stadler, B.M. und Daniel U. Habegger. Genveränderte Lebensmittel sin sicherer. Thuner Tagblatt, Nr. 036,Seite 17: 13. 2. 1997I-21.Stadler, B.M. und Daniel U. Habegger. Neue Technologien haben immer Angst gemacht. Neue MittellandZeitung, PMA-Nr. 111.2991. 1. 3. 1997I-22. Kaufmann, M. und Stadler, B.M. Die Revolutionäre sind wir. Montagsinterview Berner Tagwacht, Seite 2:21. 4. 1997I-23. von Euw, R., Wernle, N. und Stadler, B.M. Der Glaubenskrieg um Genfood. Report Brückenbauer, 47: 25-27. 1997I-24.I-25.I-26.I-27.I-28.I-29.Förger D. Stadler, B.M. Sachliche Argumente statt Polemik. Veranstaltung des Axel Springer Verlags zurAkzeptanz der Gentechnik - Entwicklungen in den letzten 25 Jahren(http://www.welt.de/daten/1997/07/12/0712ws91394.htx). Die Welt 12.7.1997Stadler, B.M. Gentechnisch veränderte Lebensmittel: Wie gross ist das Allergierisiko?. SchweizerischeGewerbezeitung, Nr. 28. 1997:Stadler, B.M und Conrad Engler. Allergie-Entwarnung dank Labortest. In: CH-Forschung, Herausgeber.Gesellschaft Schweizer Forschungsinformation Zürich, Nr. 8: 20.(http://www.interpharma.ch/news/biogen/labormagen.html), 1997Geiselmann F. und Stadler, B.M. Schadstoffe und Allergien: Umweltemmissionen und die Rolle desImmunsystems. UNIPRESS 94, ed. Pressestelle der Universität Bern, 28-30. 1997Stadler, B.M. Impfung gegen Neurodermitis und Allergien im Labor geglückt. In: Interne Klinikzeitung derAlexanderhausklinik Davos 4:13-15, (http://www.alexanderhausklinik.ch/kliztg/aerzte/497/impfung.htm)1997Geiselmann F. und Stadler, B.M. Der „Labor-Magen“ - eine Neuanwendung des Inselspitals. Allergie-Entwarnung dank Labor-Test. UNIPRESS-95. (http://pr-server.unibe.ch/unipress/heft95/beitrag10.html),1997I-30. Stadler, B.M. Absurd und Bilderstürmerisch: Standpunkte. Der Bund, 11. Mai 1998, S. 10.I-31.Faust W. und Stadler, B.M. Genfood genauso sicher wie Babyfood. Grünwalder Gespräche. Topic PRHomepage. (http://www.topic-pr.com/genfood.htm), 1998I-32. Stadler, B.M. Horrorszenarien. Berner Zeitung 30. Mai 1998, S. 5.I-33. Stadler, B.M. Gibt es Allergierisiken bei Gentechnik-Nahrung? Impuls 4:8-10, 1998I-34. Stadler, B.M. Das Thema Sicherheit. Monsanto Homepage. Hintergrund Informationen.(http://www.monsanto.de/infos/hintergrund/leaflet/teil-4.htm), 1998I-35.Fistarol C. und Stadler, B.M. Ist „Genfood“ ein Auto mit oder ohne Bremsen? Round table Genfood. A laCarte. B+L Verlags AG. Schlieren. 2:18-22, 1998I-36. Stadler, B.M. „Genhysterien um Genfood“ Schweizerische Ärztezeitung 79: 573-577, 1998I-37.I-38.Stadler, B.M. „Gentechnologie oder Genschutz“, An der Schwelle zum 21. Jahrhundert Kaderseminar desEidgenössischen Militärdepartements. Sonderdruck. 15-22, 1998Theler, L. und Stadler, B.M. „Wir bekommen die strengsten Gengesetze der Welt“, in: Walliser Bote. Nr.26: 6-7, 1998I-39. Stadler, B.M. „Bern, im August 2004“, in: funk/food/generation. Ed Cello rohr. ISBN 3-9521601-0-5, 1998

C.V.: Beda M. Stadler page 32I-40.I-41.I-42.I-43.Stadler, B.M. Sichere Nahrungsmittel / Wie genetisch veränderte Pflanzen als Ausgangsstoffe fürNahrungsmittel geprüft werden. Gibt es durch transgene Pflanzen mehr Allergien? Ärzte Zeitung.(http://www.arztonline.de/de/htm/net/allergie/197a0401.htm). 1998Stadler, B.M. Schadstoffe und Allergien: Serie Umweltmedizin: Umweltemmissionen und dasImmunsystems. ORL Highlights Fortbildung für praktizierende Ärzte. Nachdruck aus UNIPRESS 94, 6:20-22, 1998Stadler B. M. Food Safety: Der kleine Unterschied. Internutrition. Forum. Informationen über Lebensmittel,Gentechnologie (Gentechnik) und Biotechnologie. Internutrition Homepage(http://www.internutrition.ch/forum/stadler.html). 1999Stadler B. M. Interessantes aus Küche und Keller. "Genfood geht schwieriger durch den Kopf als durch denMagen" Die Harzer Köche im Internet (http://www.harzer.koeche.harz.de/Interessantes/Genfood.html)1999I-44. Rödder H. D. und Stadler B. M. Gentechnik: Chance für Allergiker. Ärzte Zeitung.(http://www.arztonline.de/de/htm/net/allergie/002a0205.htm).1999I-45.I-46.Stadler, B.M. Immunologie, ein wissenschaftliches und gesellschaftliches Minenfeld. LABOLIFE. Editorial.Nr. 2, 2000Stadler, B.M. Ein kleiner Schritt für die Menscheit, aber ein grosser für die Genforscher. Kolumne: DerBund, Tribüne, S. 3.,15. April 2000I-47. Stadler, B.M. Interview. Rifkin Strikes Out With Swiss Scientists. Science Volume 288, Number 5474:2127. 2000I-48.I-49.I-50.I-51.I-52.Stadler, B.M. Session Summary: Antibody production. In: Progress in the Reduction, Refinement andReplacement of Animal Experimentation.. Eds. M. Balls, A.-M. van Zeller and M.E. Halder. ElsevierScience B.V. Development in Animal and Veterinary Sciences. Vol. 31: 853-855. 2000Roth H. P. und Stadler, B.M. Menschliches Erbgut entschlüsselt. Genomforschung als Kulturgut. WissenBerner Zeitung, Seite 6: 20. 5. 2000Christen M. und Stadler, B.M. Traurige Immunologen. Die Neuausrichtung des Basler Instituts fürImmunologie schadet der Schweizer Forschung. Tagesanzeiger. Seite 48. 16. 6. 2000Stadler, B.M. Gründerjahre für die biomedizinische Biotechnologie in der Schweiz In: FUTURA:Biotechnologie Schweiz. Eds. M. Salm, Stab des Scheizerischen Wissenschafts und Technologierates.Vol. 1-2: 14-16. 2000Stadler, B.M. Dinner persönlich. In: Was...Wer...Wo... Informationsorgan der Berner Wirtschaftskammerder Jungen. 7: 10-11. 2000I-53. Stadler, B.M. Von der Symptom- zur Ursachentherapie. In: Life Sciences: Novartis Pharma Schweiz. 7.2000I-54.Michael Hagmann. Der forsche Forscher. Querdenker Beda Stadler hat eine wirksame Waffe gegenAllergien und Asthma entwickelt. Sonntags Zeitung. Innovation.(http://www.sonntagszeitung.ch/sz/szFeinRubrik.html?ArtId=60872& ausgabeid=483&rubrikid=109). 07.01.2001.I-55. Fredy Gasser. Interview. Beda Stadler: «Die Verantwortung tragen wir alle», BernerZeitung BZ: 13.Februar 2001I-56. Marcel Suter. Interview. Beda Stadler. Der mit den Mäusen experimentiert. Saemann. Seite 2, 3. 2001I-57. Käther Bänziger. Interview. Immun dank Dreck? Wir Eltern Seite 50-51. 4, 2001

C.V.: Beda M. Stadler page 33I-58.Felix Wüst. Interview. Beda Stadler: «Mehr als ein Drittel der Schweizerbevölkerung leidet an allergischenErkrankungen – Tendenz steigend», Swiss Med Schweiz. Zeitschrift für Medizin und medizinischeTechnik: 2. 2001I-59. Alfred Lienhard und Winfried Powollik. Interview. Beda Stadler: Anti IgE Therapie: InnovativesBehandlungskonzept bei Allergien. Medical Tribune. Wochenzeitung für den Schweizer Arzt. InternalMedical Report. 22:7. 2001I-60.I-61.I-62.I-63.I-64.I-65.Karin Oehmigen. Buchbesprechung (Trend-Essen): Experimentalküche. Ein Wissenschafter macht mobil.Sonntags Zeitung 22.07.2001Elsbeth Hobmeier. Interview. Beda Stadler: Unser täglich Brot? Alles Genfood sagt der Herr Professor,BernerZeitung (Essen & Trinken, Seite 3): 11. August 2001Anke Fossgreen. Interview. Beda Stadler: Ein Hobbykoch im Dienste des Genfoods Tages-Anzeiger(Wissen) 23.08.2001Felix Wüst. Interview. Beda Stadler: Mehr als ein drittel der Schweizer Bevölkerung leidet an allergischenErkrankungen – Tendenz steigend Swiss Pharma (Immunologie) Seite 5-12 Nr 10 23 2001Oliver Driesen. Interview. Klaus Amman und Beda Stadler. Zwei Forscher zwischen Wissenschaft undKommerz. Die Woche. 48/01, 23. November. S16-18. 2001Thomas Deichmann. Buchbesprechung. Gene an die Gabel von Beda Stadler. Gene im Suppentopf.NOVO Nr. 55/56. Seite 27. 2001I-66. Andrea Six. Buchbesprechung. Gene an die Gabel von Beda Stadler. Bio World Nr. 6. Seite 57. 2001I-67.I-68.I-69.I-70.I-71.Felix Wüst. Interview. Beda Stadler: Mehr als ein drittel der Schweizer Bevölkerung leidet an allergischenErkrankungen – Tendenz steigend Swiss Dent (Immunologie) Seite 10-15 Nr 12 2001Andrea Six. Interview. Beda Stadler. Buch-Tipp für Unvoreingenommene.Gene in die Pfanne – Gene an dieGabel. Chemische Rundschau. 24/01, 21. Dezember. S21. 2001Beat Glogger. Buchrezension und Editorial. Agent provocateur, Schweizer Forschungsmagazin. HorizonteNr. 52. Seite 25. 2002,Judith Kösters. Interview. Ernährung, Mit Hilfe der Genmanipulation können wir den Hunger besiegen.Chrismon Das evangelische Magazin. Nr. 6. Seite 7. 2002,Holger Beckmann, Moderation: Gentechnisch veränderter Raps auch in deutschem Honig - müssen sichdie Verbraucher Sorgen machen? Interview – Morgenecho WDR 5, Sendung vom 06. 07. 2002I-72. Beda Stadler. Genes on the fork. Syngenta Lectures. Exerpta Medica 2002. ISSN 1570-3347. page 28-31.2002I-73. Beda M. Stadler. Mit einem blauen Auge davongekommen. Standpunkt. Berner Zeitung. 5. Okt. 2002.I-74.Beda M. Stadler. Das Ende der Informationsflut? Editorial. Ärztemagazin Inselspital, Frehner ConsultingAG, Hebst 2002.I-75. Beda M. Stadler. Geistige Verunreinigung. Kolumne auf Einladung. Berner Zeitung. 4. Januar. 2003I-76. Beda M. Stadler. Ein Moratorium für Biogemüse?. Kolumne auf Einladung. Berner Zeitung. 1. März. 2003I-77.Beda M. Stadler. Das Recht auf Abgrenzung gegen Scharlatanerie. Kolumne auf Einladung. BernerZeitung. 26. April. 2003I-78. Urs Wüthrich. Genom entziffert: Alles halb so wild. Interview. Berner Zeitung. 15. April. 2003I-79.Beda M. Stadler. Europa hat Fieber - oder doch nicht? Kolumne auf Einladung. Berner Zeitung. 21. Juni.2003

C.V.: Beda M. Stadler page 34I-80.Beda M. Stadler. Biete 1000 Franken zum Letzten. Kolumne auf Einladung. Berner Zeitung. 20. August.2003I-81. Beda M. Stadler. Vorsicht! Granderwasser muss giftig sein. Kolumne auf Einladung. Berner Zeitung. 11.Oktober. 2003I-82.Beda M. Stadler. Strings und der St. Nikolaus. Kolumne auf Einladung. Berner Zeitung. 06. Dezember.2003I-83. Beda M. Stadler. Nach mir die Sintflut. Kolumne auf Einladung. Berner Zeitung. 31. Januar. 2004I-84. Beda M. Stadler. Spinnen die Vegetarier? Kolumne auf Einladung. Berner Zeitung. 27. März. 2004I-85. Beda M. Stadler. Achtung, blaue Kartoffeln! Kolumne auf Einladung. Berner Zeitung. 17. Juli. 2004I-86.I-87.Beda M. Stadler. Gendoping ist in Athen erlaubt. Kolumne auf Einladung. Berner Zeitung. 14. August.2004Beda M. Stadler. KTI lanciert Discovery Projekte. BIO WORLD. Magazin für molekularbiologische undbiotechnologische Applikationen. Seite 28. Vol 04. 2004I-88. Beda M. Stadler. Immun durch "Bisi"? Kolumne Berner Zeitung. 11. September 2004I-89. Beda M. Stadler. Politisch korrekte Biowaffen. Kolumne Berner Zeitung. 4. November. 2004I-90. Beda M. Stadler. Gleich dumm ins neue Jahr Kolumne Berner Zeitung 2005I-91. Beda M. Stadler. Die geistige Verunreinigung in der Alternativmedizin. Op-Ed NZZ am Sonntag. 2005I-92. Beda M. Stadler. Bio gegen Bio Kolumne Berner Zeitung. 17. Januar 2005I-93. Beda M. Stadler. und sie wirken doch... Kolumne Berner Zeitung 8. Mai 2005I-94. André F. Lichtschlag (Interview) Lecker essen statt grün morden. ef-magazin Mai 2005I-95. Simon Brunner (Interview) Eines hilft bestimmt: Recht haben. Weltwoche Nr 23 2005I-96. Beda M. Stadler. Ein Design Baby zur Volkserziehung. Kolumne NZZ am Sonntag 12. Juni 2005I-97. Beda M. Stadler. Ein Herz für die Schwarzwaldklinik. Kolumne Weltwoche Nr 25. 2005I-98. Beda M. Stadler. 2. Juli ein neues Ballenberg Kolumne. Berner Zeitung 2. Juli 2005I-99. Beda M. Stadler. Hunde werden geimpft, Kinder nicht. Kolumne. NZZ am Sonntag 10.Juli 2005I-100. Michael Feller (Interview) vom Elfenbeinturm zum Forum Von Däniken. UNIKUM Nr 115, Juli 2005I-101. Beda M. Stadler. Ein Trostpflästerchen fürs Volk. Kolumne. NZZ am Sonntag 7. Aug. 2005I-102. Beda M. Stadler. Gebt uns die Pommes frites zurück! Kolumne. Berner Zeitung 27. Aug. 2005I-103. Beda M. Stadler. Steht Bio drauf, wird applaudiert Kolumne. NZZ am Sonntag 28. Aug. 2005I-104. Beda M. Stadler. Die Mär vom unabsehbaren Risiko Kolumne. NZZ am Sonntag 25. Sept. 2005I-105.Oliver Prange (Interview, Fotos Marc Wetli) Mut oder Leichtsinn aus Sicht des Akademikers. PersönlichSeptember 2005I-106. Barbara Reye (Interview) Ein Professor will Tamiflu für alle. Tages Anzeiger. 14. Okt. 2005I-107. Fredi Gasser (Interview) Wir sind mündig genug für Tamiflu. Berner Zeitung. 15. Okt. 2005I-108. Beda M. Stadler. Mächtig stolz auf die UNI. Berner Zeitung. 22. Okt. 2005I-109.Beda M. Stadler. Vogelgrippe: Unternimmt der Bund zu wenig? Die Behörden wollen besonnen auf dasVirus reagieren, teilweise wird ihnen aber Verharmlosung vorgeworfen. Basler Zeitung 22. Okt. 2005

C.V.: Beda M. Stadler page 35I-110. Beda M. Stadler. Eine neue Initiative braucht das Land. NZZ am Sonntag 23. Okt. 2005I-111. Beda M. Stadler. Resistent gegen Fakten. Weltwoche 27. Okt. 2005I-112. Stefan Bühler (Interview) Wenn ich sicher bin, dann bin ich sicher. Der Bund 05. Nov. 2005I-113. Beda M. Stadler. Diskriminieren Sie alte Menschen?. NZZ am Sonntag 20. Nov. 2005I-114. Beda M. Stadler. Bambi, Sex und Bibelis. Sonntagsblick 20. Nov. 2005I-115. Beda M. Stadler. Ist Bio drin, kommt's von weit her. NZZ am Sonntag 18. Dez. 2005I-116. Beda M. Stadler. Glauben Sie an den Samichlaus? Berner Zeitung. 24. Dez. 2005I-117.Franziska Ramser (Portrait Beda Stadler) Alles was wir essen ist genetisch verändert). Naturschutzblätter46-47. 01: 2006I-118. Beda M. Stadler. Entschlackung fürs Gehirn. NZZ am Sonntag 15. Jan. 2006I-119. Beda M. Stadler. Glauben Sie an den Samichlaus? Berner Zeitung. 24. Dez. 2005I-120. Beda M. Stadler. Arme kleine Schweine. NZZ am Sonntag 12. Feb. 2006I-121. Beda M. Stadler. Das nächste Erdbeben kommt bestimmt. Bieler Tagblatt 2. März 2006I-122. Beda M. Stadler. Gesichtsmasken für jeden Schweizer. NZZ am Sonntag 12. März 2006I-123.Franziska Richard (Interview) Wellness ist eine Placebo lndustrie. H&T Revue 16. MärzI-124. Beda M. Stadler. Heisse Luft um den Terminator Berner Zeitung. 18. März 2006I-125. Beda M. Stadler. Sollen Hühner Veganer werden? NZZ am Sonntag 9. April 2006I-126. Beda M. Stadler. Googeln Sie ihr Privatleben. Berner Zeitung. 29. April 2006I-127. Beda M. Stadler. Wenn Medikamente töten. NZZ am Sonntag 7. Mai 2006I-128. Beda M. Stadler. Der Generika-Rappen. NZZ am Sonntag 4. Juni 2006I-129. Beda M. Stadler. Nicht wissen kann kriminell sein. Berner Zeitung. 10. Juni 2006I-130. Beda M. Stadler. Verworrene Netzwerke. NZZ am Sonntag 2. Juli 2006I-131.Beda M. Stadler. Wer Spitzenmedizin sagt, meint Zweitklassmedizin FACTS 6. JuliI-132. Beda M. Stadler. Auf zum Pilzesammeln! Berner Zeitung. 22. Juli 2006I-133. Beda M. Stadler. Schlank dank Wissenschaft. NZZ am Sonntag 30. Juli 2006I-134. Beda M. Stadler. Salonfähiger Ökoterrorismus. NZZ am Sonntag 27. August 2006I-135. Beda M. Stadler. Verblüffende Ehrlichkeit Berner Zeitung. 2. September 2006

C.V.: Beda M. Stadler page 36AbstractsA-1.A-2.A-3.A-4.A-5.A-6.A-7.A-8.A-9.A-10.A-11.A-12.A-13.A-14.A-15.A-16.A-17.A-18.A-19.A-20.A-21.Stadler, B.M., Lazary, S., Farah, F.S., and de Weck, A.L. A quantitative radioisotopical method for differentialmeasurement of phagocytosis or membrane attachment of Leishmania tropica by mouse macrophages. Z.Immun. Forsch. 152: 117, 1976.Stadler, B.M., and de Weck, A.L. Evaluation of macrophage activity by flow-cytometric analysis of cellularRNA content. Z. Immun. Forsch. 155: 65, 1978.Stadler, B.M., and de Weck, A.L. Macrophage activation: Increased cellular RNA content as a parameter todistinguish between normal and activated macrophages. 4th European Immunology Meeting, Budapest-Hungary, 1978.Stadler, B.M., Nakagawa, T., and de Weck, A.L. Flow-cytometric determination of rat mast cells and humanbasophilic granulocytes. X. International Congress of Allergology, 1979.Stadler, B.M., and de Weck, A.L. Analysis of macrophage stimulation and of substances influencingmacrophage functions by flow cytometry. FASEB, 1979.Nakagawa, T., Stadler, B.M., and de Weck, A.L. Determination of rat mast cells by flow-cytometry.International Symposium: The Mast Cell - it's Role in Health and Disease. Hamburg, 1979.Stadler, B.M., and de Weck, A.L. Influence of human lymphokines on the RNA content of mouse peritonealmacrophages. Second International Lymphokine Workshop. Ermattingen, Switzerland, 1979.Schnyder, J., Stadler, B.M., Baggiolini, M., and de Weck, A.L. Macrophage activation: Correlation of enzymelevels and secretion rates with cellular RNA. 12th Annual Meeting of the USGEB (USSBE), March 13-14,1980.Stadler, B.M., Moore, R.N., Schnyder, J., and de Weck, A.L. Macrophage RNA content as marker fordifferent subpopulations. FASEB, 1980.Luger, T.A., Stadler, B.M., Oppenheim, J.J., and Katz, S.I. A thymocyte activating factor produced by amurine keratinocyte cell line. The Society for Investigative Dermatology. Clinical Research 29/2: 605A,1981.Nies, M., Louie, J.S., Stadler, B.M., Farrar, J.F., and Nies, K.M. Counterflow centrifugation-elutriation (CCE)of T lymphocytes into G0 and G1 fractions possess different capabilities to produce interleukin 2 (IL-2).American Federation for Clinical Research, Clinical Research 29/2: 486A, 1981.Timonen, T., Stadler, B.M., Ortaldo, J.R., Bonnard, G.D., and Herberman, R.B. Cultures of human naturalkiller cells in the presence of T cell growth factor (TCGF) containing conditioned medium (CM). 14thInternational Leucocyte Culture Conference. 1981.Domzig, W., Timonen, T.T., and Stadler, B.M. Human natural killer (NK) cells produce Interleukin 2 (IL-2).AACR 1981.Luger, T.A., Stadler, B.M., and Oppenheim, J.J. Thymocyte proliferative activity produced by a keratinocytecell line. 14th International Leucocyte Culture Conference, Heidelberg. Immunobiol. 159: 200, 1981.Stadler, B.M., Dougherty, S.F., Berenstein, E.H., Fox, P.C., Siraganian, R.P., and Oppenhaim, J.J.Monoclonal antibodies against human interleukin 2. 14th International Leucocyte Culture Conference,Heidelberg. Immunobiol. 159: 199, 1981.Oppenheim, J.J., Stadler, B.M., Luger, T., Sztein, M., and Steeg, S. Circuit of cytokine-macrophagelymphocyteinteractions that amplify immunological and inflammatory reactions. NAITO FoundationInternational Symposium on Self-Defense Mechanisms. Role of Macrophages. Tokyo, 1981.Stadler, B.M., Berenstein, E.H., Siraganian, R., and Oppenheim, J.J. Charge hererogeneity of humaninterleukin 2 (IL-2) and inhibition of IL-2 activity by supernatants of hybridomas generated from spleen cellsimmunized with IL-2. FASEB, 1981.Domzig, W., Stadler, B.M., and Herberman, R.B. Relation between human killer cells activity and interleukin2. 5th European Immunology Meeting, 1982.Stadler, B.M., Bonnard, G.D., and de Weck, A.L. T cell stimulating lectins are mitogen inducers but notmitogens. Interlec 5, 1982.Stadler, B.M., Liechti, J., de Weck, A.L. Correlation between resistance markers and Interleukin 2 productionof the HSB-2 T cell line. 15th International Leucocyte Culture Conference, 1982.Tadokoro, K., Stadler, B.M., and de Weck, A.L. In vitro growth of normal bone marrow-derived humanbasophils and the comparison of the cells to bone marrow-derived mouse mast cell like cells. 15thInternational Leucocyte Culture Conference, 1982.

C.V.: Beda M. Stadler page 38A-46.A-47.A-48.A-49.A-50.A-51.A-52.A-53.A-54.A-55.A-56.A-57.A-58.A-59.A-60.A-61.A-62.Stadler, B.M., Hirai, K., Tadokoro, K., and de Weck, A.L. Distinction of the human basophil promoting activityfrom a human IL-3-like factor. Fourth International Lymphokine Workshop, Schloss Elmau, Klais, October17-21, 1984.de Weck, A.L., Stadler, B.M., Bettens, F., Joncourt, F., Walker, C., and Kristensen, F. Interleukin 2 and otherimmunoregulatory T cell lymphokines: Biological significance. IUPHAR 9th International Congress ofPharmacology, 1984.Stadler, B.M., Knutti-Müller, J., and de Weck, A.L. Human IgE binding factor produced by T cell hybridomas.American Academy of Allergy and Immunology, 1984.de Weck, A.L., Stadler, B.M., Knutti-Müller, J. IgE regulating factors. New Trends in Allergy II, Munich, July,26-28, 1985.de Weck, A.L., Stadler, B.M., Hirai, K., Kings, M. Allergic responses: Triggering and mediators. 7thEuropean Immunology Meeting, Jerusalem, Israel, September 8-13, 1985.Derer, M., Stadler, B.M., de Weck, A.L., Didier-Laurent, A., Leroy, A.M., Guérin, B. Dast IgE, a new systemfor detection of total and specific IgE. Int. Congress of Allergology, 1985.Derer, M., Stadler, B.M., Gruden, E., de Weck, A.L., Guérin, B. Dast IgG, a new system for detection ofspecific IgG and followup of immunotherapy. Int. Congress of Allergology, 1985.Stadler, B.M., Hirai, K., de Weck, A.L. Growth of basophil-like or mast cell-like cells from human bonemarrow promoted by different factors. Int. Congress of Allergology, 1985.Stadler, B.M., Hildbrand, M.-L., Yang, X., Gauchat, J.-F., Gauchat, D., de Weck, A.L. T-hybridoma derivedimmunoglobulin binding factors. Int. Congress of Immunology, 1986.Stadler, B.M., Hirai, K., Walz, A., de Weck, A.L. Human mast cell growth factor, Int. Congress ofImmunology, Toronto 1986.Stadler, B.M., Hildbrand, M.-L., Gauchat, J.-F., Yang, X., and de Weck, A.L. Role of immunoglobuline bindingfactors in the regulation of human IgE synthesis. USGEB, 1986.Stadler, B.M., Gauchat, D., Hildbrand, M.-L., Yang, X., and de Weck, A.L. Human T-hybridoma derivedimmunoglobulin binding factors. Collegium Internationale Allergologicum, 1986.Stadler, B.M., Hirai, K., Nakajima, K., and de Weck, A.L. Biochemical characterization of BaPA. CollegiumInternationale Allergologicum, 1986.de Weck, A.L., Stadler, B.M., Gruden, E., Derer, M., Hauzenberger, B., Wälti, M. Entwicklung serologischerSchnellverfahren zur Bestimmung der beruflichen Allergenexposition. Schweiz. Gesellschaft fürArbeitsmedizin, 1986.Yang, X.D., Hildbrand, M.-L., Gauchat, D., de Weck, A.L., Stadler, B.M. Influence of immunoglobulin bindingfactors on the human in vitro immunoglobulin synthesis. Joint Meeting of the Gesellschaft für Immunologieand the Société Francaise d'Immunologie, 1986.Brantschen, St., Nakajima, K., de Weck, A.L., and Stadler, B.M. Factors influencing cellular histaminecontent of human cultured bone marrow cells. Joint Meeting of the Gesellschaft für Immunologie and theSociété Francaise d'Immunologie, 1986.Gauchat, J.-F., Walker, Ch., de Weck, A.L., and Stadler, B.M. Independent induction of different lymphokinemRNAs in human peripheral blood lymphocytes. Joint Meeting of the Gesellschaft für Immunologie and theSociété Francaise d'Immunologie, 1986.A-63. Stadler, B.M. The role of lymphokines in allergy. ESPHI, Gardone Riviera, Eur. J. Pediatr.146: 341. 1987.A-64.A-65.A-66.A-67.A-68.A-69.Vassella, C., Gauchat, J.-F., de Weck, A.L., and Stadler, B.M. Effect of ciclosporin A on lymphokine mRNAlevels. Int. Arch. Allergy appl. Immunol. 83/S1: 19, 1987.Brantschen, St., de Weck, A.L., and Stadler, B.M. Factors influencing growth and differentiation of humanbasophil- and mast cell-like cells. Int. Arch. Allergy appl. Immunol. 83/S1: 23, 1987.Gauchat, J.-F., de Weck, A.L., and Stadler, B.M. Impaired lymphokine mRNA production in lymphocytes fromelderly individuals. Int. Arch. Allergy appl. Immunol. 83/S1: 26, 1987.Yang, X.D., Gauchat, D., de Weck, A.L., and Stadler, B.M. Induction of in vitro human IgE synthesis via T cellstimulation. Int. Arch. Allergy appl. Immunol. 83/S1: 35, 1987.Bell, S.J.D., Bättig, M., Stadler,B.M., de Weck, A.L. Development and standardization of a dotimmunobindingassay for the diagnosis of milk allergy. Int. Arch. Allergy appl. Immunol. 83/S1: 36, 1987.Stadler, B.M., and de Weck, A.L. Growth and differentiation factors for human metachromatically stainingcells. Fifth International Lymphokine Workshop, Clearwater Beach, Florida, January 11-15, 1987.A-70. Walz, A., Böhlen, P., Hirai, K., and Stadler, B.M. Human IL-3 like activity shows sequence homology with G-CSF. Fifth International Lymphokine Workshop, Clearwater Beach, Florida, January 11-15, 1987.

C.V.: Beda M. Stadler page 39A-71.A-72.A-73.A-74.A-75.A-76.A-77.A-78.A-79.A-80.A-81.A-82.A-83.A-84.A-85.A-86.A-87.A-88.A-89.A-90.A-91.A-92.A-93.A-94.Gauchat, J.-F., Stadler, B.M., and de Weck, A.L. Study on lymphokine gene expression in lymphocytes fromelderly individuals. 2nd Intern. Congress of Biomedical Gerontology, Hamburg, July 15-18, 1987.Felix, R., Elford, P., Stoercklé, C., Cecchini, M., Trechsel, U., Fleisch, H., and Stadler, B.M. Production ofcolony stimulating factors by calvaria and bone cells. American Soc. of Cell Biology, St. Louis, 1987.Pichler, W.J., Schindler, L., Stäubli, M., Stadler, B., de Weck, A.L. Nachweis von anti-Amiodaron Antikörpern.56. Jahresversammlung der Schweiz. Ges. für Innere Medizin, Basel, 5.-7. Mai, 1988.Fagg, B., Hirai, K., Nakajima, K., and Stadler, B.M. Human rIL-3 promotes the growth of human basophils.UCLA Symposium "Therapeutic Applicants of Biologicals", Keystone, April, 1988.Stadler, B.M., Nakajima, K., Yang, X., and de Weck, A.L. Potential Role of anti IgE antibodies in vivo. 17thSymposium of the Collecium Internationale Allergologicum, Fort-de-France, Martinique, March 5-10,1988.Yang, X.D., Gauchat, D., de Weck, A.L., and Stadler, B.M. Human in vitro IgE synthesis induced bystimulation of T cell. Joint Meeting of the British Society for Immunology and the France Society forImmunology, Paris, April 7-8, 1988.Brantschen, S., Gauchat, J.-F., de Weck, A.L., and Stadler, B.M. Differential induction of lymphokinesmRNAs in urinary bladder carcinoma cells. SGAI, Zürich, 1988.Vassella, C., Gauchat, J.-F., de Weck, A.L., and Stadler, B.M. Effect of ciclosporin A on lymphokine andmonokine mRNA levels. SGAI, Zürich, 1988.Yang, X.D., de Weck, A.L., and Stadler, B.M. Stimulation of human in vitro IgE synthesis by recombinantinterleukin-4. SGAI, Zürich, 1988.Nakajima, K., de Weck, A.L., and Stadler,B.M. Influence of anti IgE antibodies on binding of IgE to the lowaffinity IgE receptor. SGAI, Zürich, 1988.Gauchat, J.-F., Gauchat, D., de Weck, A.L., and Stadler, B.M. Lymphokine mRNA levels in mononuclearcells after antigen stimulation. SGAI, Zürich, 1988.Gauchat, D., Gauchat, J.-F., Yang, X., de Weck, A.L., and Stadler, B.M. In vitro lymphokine gene expressionin mononuclear cells of atopic blood donors. SGAI, Zürich, 1988.Valent, P., Stain, C., Ashman, L.M., Brantschen, S.B., Stadler, B.M., Eckersberger, F., Lechner, K., andBettelheim, P. The immunological phenotyp of human mast cells. The American Society of Hematology.29th annual meeting, 1988Vassella, C., Gauchat, J-F., de Weck A.L., and Stadler, B.M. Importance of IL-2 gene expression for theaction of cyclosporin A. Ninth Eur. Immunol. Meeting, Rome. W26-37. p. 329, 1988Gauchat, J-F., Gauchat, D., de Weck A.L., and Stadler, B.M. Aging and lymphokine production. Ninth Eur.Immunol. Meeting, Rome. W11-3. p. 136. 1988Brantschen, S., Gauchat, J-F., de Weck, A.L., and Stadler, B.M. Expression of mRNAs coding for humanlymphokines involved in hemopoiesis. Ninth Eur. Immunol. Meeting, Rome. W26-25. p. 326. 1988Gauchat, D., Gauchat, J-F., de Weck A.L., and Stadler, B.M. Lymphokine gene expression in mononuclearcells from atopic blood donors. Ninth Eur. Immunol. Meeting, Rome. W14-18. p. 160. 1988Sandru, D., Veraguth, P., and Stadler, B.M. Dual influence of mononuclear cell products upon tumor cellgrowth in vitro. Ninth Eur. Immunol. Meeting, Rome. W16-15. p. 175. 1988Gauchat, J-F., de Weck A.L., and Stadler, B.M. Stimulation dependent lymphokine gene expression. Sixthinternational lymphokine workshop. Evian, 23-27 Oct. 1988Gauchat, J-F., Gauchat, D., de Weck A.L., and Stadler, B.M. Aging and lymphokine production. 13thInternational Congress of Allergy and Clinical Immunology. New England and Regional AllergyProceedings. 9: 315 NO.266. 1988Gauchat, D., Gauchat, J-F., de Weck A.L., and Stadler, B.M. Lymphokine gene expression in mononuclearcells from atopic blood donors. 13th International Congress of Allergy and Clinical Immunology. NewEngland and Regional Allergy Proceedings. 9: 269. NO.83. 1988Vassella, C., Gauchat, J-F., de Weck A.L., and Stadler, B.M. Relevance of IL-2 for the action of CyclosporinA. 13th International Congress of Allergy and Clinical Immunology. New England and Regional AllergyProceedings. 9: 315 NO.267. 1988Brantschen, S., Gauchat, J-F., de Weck, A.L., and Stadler, B.M. Human lymphokines involved inhemopoiesis: regulation of mRNA synthesis. 13th International Congress of Allergy and Clinical Immunology.New England and Regional Allergy Proceedings. 9: .316 NO.271. 1988Yang, X., de Weck, A.L., and Stadler, B.M. The role of rIL-4 in human in vitro IgE synthesis. 13thInternational Congress of Allergy and Clinical Immunology. New England and Regional AllergyProceedings. 9: 268 NO.80. 1988

C.V.: Beda M. Stadler page 40A-95.A-96.A-97.A-98.A-99.A-100.A-101.A-102.A-103.A-104.A-105.A-106.A-107.A-108.A-109.A-110.A-111.A-112.A-113.A-114.Qiu, G., Gauchat, J-F., Gauchat, D., de Weck, A.L., and Stadler, B.M. Assessment of lymphokine mRNAexpression in human lymphocytes by in situ hybridization. 13th International Congress of Allergy and ClinicalImmunology. New England and Regional Allergy Proceedings. 9: 316 NO.269 1988Nakajima, K., Gauchat, D., Yang, X., Hildbrand, M-L., de Weck, A.L., and Stadler, B.M. In vitro activity ofnaturally occuring human IgG anti-IgE antibodies. 13th International Congress of Allergy and ClinicalImmunology. New England and Regional Allergy Proceedings. 9: 303 NO. 218. 1988Stadler, B.M., Loidolt D., Qiu, G., Vassella, C., Nakajima, K., Gauchat, J-F., Gauchat, D., and de Weck A.L.,Funktionelle Aspekte von auto anti-IgE Antikörper. 57. Jahresversammlung der SchweizerischenGesellschaft für Innere Medizin, Interlaken. Schweizerische Medizinische Wochenschrift. suppl. 28:7.1989Brantschen, St., Gauchat, J-F., de Weck, A.L., and Stadler, B.M. Influence of human recombinant IL-3 andIL-4 on cytokine gene expression of bone marrow cells and peripheral blood mononuclear cells. Meeting ofthe Swiss immunology students, Ermattingen, May 10-12, 1989Vassella, C., Nakajima, K., de Weck A.L., and Stadler, B.M. Purification of anti-IgE auto antibodies. Meetingof the Swiss immunology students, Ermattingen, May 10-12, 1989Vogel, M., Qiu Gang, de Weck A.L., and Stadler, B.M. Production of human immunoglobulin E epsilon chainin E. coli. Meeting of the Swiss immunology students, Ermattingen, May 10-12, 1989Qiu Gang, Vassella, C., Nakajima, K., Gauchat, J-F., de Weck A.L., and Stadler, B.M. Human PBLproliferation stimulated by anti-IgE antibodies. Meeting of the Swiss immunology students, Ermattingen,May 10-12, 1989Vassella, C., Nakajima, K., Loidolt, D., de Weck A.L., and Stadler, B.M. Functional characteristics of anti-IgEauto antibodies. 7th International Congress of Immunology, Berlin FRG, Abstracts, Gustav FischerVerlag, Stuttgart New York. Abstr. 74-19, p. 456. 1989Qiu Gang, Vassella, C., Nakajima, K., Gauchat, J-F., de Weck A.L., and Stadler, B.M. Human PBLproliferation stimulated by anti-IgE antibodies. 7th International Congress of Immunology, Berlin FRG,Abstracts, Gustav Fischer Verlag, Stuttgart New York. Abstr. 75-33, p. 462. 1989Sandru, G., Veraguth, P. and Stadler, B.M. A MNC-derived bifunctional regulatory factor for tumor cellgrowth. 7th International Congress of Immunology, Berlin, FRG, Abstracts, Gustav Fischer Verlag,Stuttgart New York. Abstr. 102-27, p. 711. 1989Loidolt, D. and Stadler, B.M. Clinical relevance of IgG anti-IgE antibodies for immunotherapy. XIVth Congressof the European Academy of Allergology and Clinical Immunology, Berlin, Sept. 17-22. Allergologie, B1366ESondernummer, p8. 1989De Weck, A.L., Derer, M., Stadler, B,. Bättig, M., Seger, R., and Hess, S. Simple and rapid determination oflow level IgE and IgG anti-IgE complexes in cord blood sera by an immunodot strip. XIVth Congress of theEuropean Academy of Allergology and Clinical Immunology, Berlin, Sept. 17-22. Allergologie, B1366E,Sondernummer, p. 49. 1989Stadler, B.M., Qiu Gang, Vassella, C., Loidolt, D., Jarolim, E., Vogel, M., and de Weck A.L. IgG anti-IgE undZytokine bei Allergischen Krankheiten. Tagung "Fortschritte der Allergologie und Dermatologie". Davos,Switzerland, Sept.13-17. 1989Jarolim, E., Vassella, C.C., Blaser, S., Vogel. M., and Stadler, B.M. A large proportion of specific IgE ishidden in complexes of IgG anti-IgE . Jahrestagung ÖGAI. Robidruck Maria Rodler G.m.b.H. Wien. 1990Gang, Qiu. Vogel, M., Gauchat, J.-F., Mandallaz, M., de Weck, A.L., and Stadler, B.M., Human IgE mRNAexpression by peripheral blood lymphocytes stimulated with interleukin 4 and pokeweed mitogen. SeronoSymposium: 1st international congress on cytokines: basic principles and clinical application. Florence.Abst. BC.12, p. 94. 1990Gang, Qiu. Vogel, M., de Weck, A.L., and Stadler, B.M., Human IgE mRNA expression by peripheral bloodlymphocytes stimulated with interleukin 4 and pokeweed mitogen. Meeting of the Swiss Ph.D. students,Bussigny, Lausanne 1990Stadler, B.M., Vogel, M., Jarolim, E., Vassella, C.C., and Gang, Qiu. Cytokines and anti-IgE autoantibodies inIgE regulation. Swiss Society of Allergology and Immunology. Abstr. D4. 1990Jarolim, E., Vassella, C.C., and Stadler, B.M. Specific IgE antibodies are hidden in complexes with anti-IgEautoantibodies. Swiss Society of Allergology and Immunology. Abstr. A2. 1990Ritter, C., Bättig, M., Kraemer, R. and Stadler, B.M. Specific IgE antibodies are hidden in complexes withanti-IgE autoantibodies. Swiss Society of Allergology and Immunology. Abstr. A18. 1990Gang, Qiu. Vogel, M., de Weck, A.L., and Stadler, B.M., Human IgE mRNA expression by peripheral bloodlymphocytes stimulated with interleukin 4 and pokeweed mitogen. Swiss Society of Allergology andImmunology. Abstr. D27. 1990

C.V.: Beda M. Stadler page 41A-115.A-116.A-117.A-118.A-119.A-120.A-121.A-122.A-123.A-124.A-125.A-126.A-127.A-128.A-129.A-130.A-131.A-132.A-133.A-134.A-135.A-136.Vogel, M., Blaser, S., Gang, Qiu. Zhang, X., Vassella, C.C., de Weck, A.L., and Stadler, B.M.,Immunogenicity of human IgE expressed in E. coli. Swiss Society of Allergology and Immunology. Abstr.A7. 1990Miescher, S., Vogel, M., Ritter, C., Jarolim, E., Bättig, M., de Weck, A.L., and Stadler, B.M. Anti-IgEautoantibodies in intravenous immunoglobulin preparations (IVIG). Intravenous ImmunoglobulinSymposium, Interlaken 1990Stadler, B.M., and Gang, Qiu. Human IgE mRNA expression by peripheral blood lymphocytes. AmericanAssociation of Immunology. New Orleans 1990Bättig, M., Derer, M., de Weck, A.L., Wirz, C. and Stadler, B.M. Messung von IgE im Nabelschnurblut mittelseines Teststreifens (Immunodot-Streifen). Schweizerische Gesellschaft für Pädiatrie. Interlaken. 1990Jarolim, E. and Stadler, B.M. Anti-IgE autoantibodies hide specific IgE and are mistaken for specific IgG. NewTrends in Allergy III. Munich. Allergologie. 7: 245. 1990Jarolim, E. and de Weck, A.L., Stadler, B.M. Are allergen specific IgG mainly anti-IgE autoantibodies? 18thSymposium of the Collegium Internationale Allergologicum. Madeira. 1990de Weck, A.L. and Stadler, B.M. Aging and Allergic Disease - a marker for immunobiological changes inaging II. European Congress of Gerontology. Madrid 1991Stämpfli, M.R., Qiu Gang, and Stadler, B.M. Translation of the germline mRNA. IV. Meeting of the SwissImmunology Ph.D. Students. Wolfsberg.1992Holzner, M.E., Vogel, M., Miescher, S., Stadler, B.M. The biological activity of the IgE CH3-domain. IV.Meeting of the Swiss Immunology Ph.D. Students. Wolfsberg.1992Miescher, S., Vogel, M., Blaser, S., and Stadler, B.M. Influence of anti-IgE antibodies and Fc peptides onIgE binding to CD23+ 8866 cells. XVth European Congress of Allergology and Clinical Immunology.Paris. 1992.Aebischer, I., and Stadler, B.M. Interleukin-4 independent induction of human IgE synthesis in vitro. XVthEuropean Congress of Allergology and Clinical Immunology. Paris. 1992.Czech, W., Stadler, B.M., Krutmann, J., Schöpf, E., and Kapp, A. Occurence of different antibodies againstthe CH3 and CH4 epitope of IgE in atopic dermatitis. XVth European Congress of Allergology andClinical Immunology. Paris. 1992.Bühlmann, U., Kraemer, R., Wirz, C., de Weck, A.L., Gugler, E., Stadler, B.M. IgE and anti-IgEautoantibodies in cord blood and 4 month sera. SGAI/SSAI. Interlaken. 1992.Aebischer, I., Stadler, B.M. Interleukin-4 independent induction of human IgE synthesis in vitro. SGAI/SSAI.Interlaken. 1992.Vogel., M., Yan Yu, Blaser, S., Müller, U., de Weck, A.L., Stadler, B.M. Epitope mapping of human anti-IgEantibodies. SGAI/SSAI. Interlaken. 1992.Furukawa, K., Miescher, S., Vogel, M. Effect of anti-IgE antibodies on IgE binding to FcRI. SGAI/SSAI.Interlaken. 1992.Miescher, S., Vogel, M., Blaser, S., Stadler, B.M. IgE binding to CD23+ 8866 cells in presence of anti-IgEantibodies and Fc peptides. SGAI/SSAI. Interlaken. 1992.Stämpfli, M.R., Gang Qiu, Stadler, B.M. The role of germline mRNA in isotype switching. SGAI/SSAI.Interlaken. 1992.Holzner, M.E., Vogel, M., Miescher, S., Stadler, B.M. Production of a biologically active CH3-domain.SGAI/SSAI. Interlaken. 1992.Bühlmann, U., Kraemer, R., Wirz, C., Stadler, B.M., Gugler, E. Die Wechselbeziehung zwischen IgE und anti-IgE autoantikörpern in den ersten Lebensmonaten bei einer Risikogruppe. Jahresversammlung Schweiz.Gesellschaft für Pädiatrie. Davos. 1992.Yan Yu, Stadler, B.M., Müller, U. Isotype and epitope specifcity of anti-IgE autoantibodies in bee venomallergy. American Academy of Allergy and Immunology. 1992.Vogel, M., Blaser, S., de Weck, A.L., Stadler, B.M. Production of recombinant anti-IgE autoantibodies.International Congress of Allergy and Clinical Immunology. Kyoto. 1992.A-137.A-138.Stämpfli, M.R., Gang Qiu, Stadler, B.M. Translation of the germline mRNA? 8th International Congress ofImmunology. Budapest. Springer Hungarica, p. 464, abstract 74-35, 1992.Vogel, M., Miescher, S., Furukawa, K., de Weck, A.L., Stadler, B.M. Epitope mapping and function of humananti-IgE antibodies. 8th International Congress of Immunology. Budapest. Springer Hungarica, p. 21,abstract 5-46, 1992.A-139. Stadler, B.M. Interference of anti-IgE antibodies in basophil and mast cell triggering. Allergy 2000International. Munich. Nov. 19-21, 1992.

C.V.: Beda M. Stadler page 42A-140.A-141.A-142.A-143.A-144.A-145.A-146.A-147.A-148.A-149.A-150.A-151.A-152.A-153.A-154.A-155.A-156.A-157.A-158.A-159.A-160.A-161.A-162.A-163.A-164.Furukawa, K, de Weck, A.L. and Stadler, B.M. Anti-IgE antibodies modify IgE. binding to FcRI. XVthEuropean Congress of Allergology and Clinical Immunology. Paris. 1992.de Weck, A.L. Furukawa, K, Urwyler, A., Stadler, B.M. Dahinden, C.A., and Maly, F.E. Sulfidoleukotriene-ELISA: A new cellular approach to the diagnostic of allergies. XVth European Congress of Allergology andClinical Immunology. Paris. 1992.Rudolf, M.P., Vogel, M., Stadler, B.M. Generation of a random epitope library of IgE. V. Meeting of theSwiss Immunology Ph.D. Students. Wolfsberg. 1993Stämpfli, M.R., Aebischer, I., Miescher, S., and Stadler, B.M. Anti-IgE monoclonal antibodies modulatehuman IgE synthesis. V. Meeting of the Swiss Immunology Ph.D. Students. Wolfsberg. 1993Kägi, M., Vogel, M., Miescher, S., Wüthrich, B., and Stadler, B.M. High levels of CH3 domain specific anti-IgE antibodies in atopic patients. American Academy of Allergy and Immunology. 1993.de Weck, A.L., Stadler, B.M., Bühlmann, R.P., Wehner, H.-U., and Urwyler, A. A new Sulfidoleukotrieneassayfor the detection and monitoring of allergies and pseudoallergies. American Academy of Allergy andImmunology. 1993.Hüppi, P., Amato, M., Ramseyer, V. and Stadler, B.M. Specific serum antibodies against curosurf. 8th Int.Workshop on Surfactant Replacement. Oslo, Norway, 1993Luger, T., Aebischer, I. and Stadler, B.M. Regulation of IgE Production and Interferon gamma synthesis byProopiomelanocortin derived peptides. The European Society for Dermatological Research. 1993Aebischer, I., Zürcher, A., Stämpfli, M.R. and Stadler, B.M. Neuroendocrine peptides modulate human IgEsynthesis. Annual Meeting of the European Academy of Allergology and Clinical Immunology.Rotterdam. 1993.Stämpfli, M.R. Aebischer, I., Miescher, S., de Weck, A.L. and Stadler, B.M. Domain specific modulation ofIgE synthesis by monoclonal anti-IgE antibodies. Annual Meeting of the European Academy ofAllergology and Clinical Immunology. Rotterdam. 1993.Stadler, B.M. Autoimmune and Neuroendocrine Regulation of the Allergic Response, Hand out: speciallecture, Basic Clinical Allergy Course, London, 1993Stadler, B.M. Die Rolle von Anti-IgE Autoantikörper, Hand out: FMH Kurs der Schweiz. Ges. fürAllergologie und Immunologie, Genf, 1993Miescher, S., Vogel., M., Biaggi, C., and Stadler, B.M. Production of recombinant anti-IgE antibodies. Annualmeeting SGAI/SSAI. Geneva. 1993.de Weck, A.L., Stadler, B.M., Müller, U., Jutel, M., Urwyler, A., and Vassella, C. The CAST: a new dimensionin Allergy research. American Academy of Allergy and Immunology. 1994.Vogel., M., Lang, A., Miescher, S., and Stadler, B.M. Utilization of phage display libraries for the production ofhuman antibodies. Annual meeting SGAI/SSAI. Basel. 1994.Stämpfli, M.R. Aebischer, I., Miescher, S., Zürcher, A. and Stadler, B.M. Mechanism of IgE synthesisinhibition by anti-IgE antibodies. SGAI/SSAI. Basel. 1994.Zürcher, A., Lang, A. Aebischer, I., Miescher, S., and Stadler, B.M. Lack of specific B cell hybridomageneration after culture in the CD40 system. VI. Meeting of the Swiss Immunology Ph.D. Students.Wolfsberg. 1994.Stämpfli, M.R. Aebischer, I., Miescher, S., Zürcher, A. and Stadler, B.M. Different mechanism of IgEsynthesis inhibition by anti-IgE antibodies. VI. Meeting of the Swiss Immunology Ph.D. Students.Wolfsberg. 1994.Zürcher, A., Lang, A. Aebischer, I., Miescher, S., and Stadler, B.M. IL-4 and CD40 antibody do not promoteexpansion of allergen-specific B cells SGAI/SSAI. Basel. 1994.Stadler, B.M. Neuroendocrine and Autoimmune Regulation of the Allergic Response, FERAI Meeting,Lausanne, 1994Vogel., M., Miescher, S., Biaggi, C., and Stadler, B.M. Production of human anti-IgE antibodies. KeystoneMeeting. T24: antibody engineering.1994.Rudolf, M.P., Vogel, M., and Stadler, B.M. Generation of a random epitope library and expression of IgEdomains. VI. Meeting of the Swiss Immunology Ph.D. Students. Wolfsberg. 1994.Stadler, B.M., Vogel, M., Rudolf, M.P., Lilin Lai Zhang and Miescher, S., From recombinant to syntheticmimotopes, European Peptide Society Meeting, Interlaken, Switzerland. 1995Vogel, M., Miescher, S., Biaggi, C. and Stadler, B.M. Cloning of anti-IgE antibodies: anti-idiotypes versusanti-isotypes, SGAI/SSAI Meeting, Lausanne-CHUV, Switzerland. 1995Miescher, S., Vogel, M., Aeby, P., Brick, B., Biaggi, C. Rudolf, M.and Stadler, B.M. Isolation of human anti-Rhesus D, SGAI/SSAI Meeting, Lausanne-CHUV, Switzerland. 1995

C.V.: Beda M. Stadler page 43A-165.A-166.A-167.A-168.A-169.A-170.A-171.A-172.A-173.A-174.A-175.A-176.A-177.A-178.A-179.A-180.A-181.A-182.A-183.A-184.A-185.A-186.Rudolf, M.. Vogel, M., Miescher, S., Kocher. H., Kricek, F.and Stadler, B.M. Inhibition of IgE binding to FcRIwithout affecting the binding site, SGAI/SSAI Meeting, Lausanne-CHUV, Switzerland. 1995Biaggi, C. Vogel, M., Lang, A., Miescher, S. and Stadler, B.M. Recombinant anti-tetanus antibodies fortherapy, SGAI/SSAI Meeting, Lausanne-CHUV, Switzerland. 1995Zürcher, A., and Stadler, B.M. B cell cultures from the nouse, SGAI/SSAI Meeting, Lausanne-CHUV,Switzerland. 1995Rudolf, M.. Furukawa, K., Vogel, M., Miescher, S.and Stadler, B.M. Binding of IgE / anti-IgE Immunecomplexes to the high affinity receptor FcRI. Meeting of the Swiss Immunology Ph.D. Students.Wolfsberg. 1995Jawien, J., Szczeklik, A., and Stadler, B.M. Human anti-IgE autoantibodies follow the rise of serumimmunglobulin E levels in response to tissue injury. Meeting of the European Society for ClinicalInvestigation. Interlaken, Switzerland, 24-27 April. 1996Horn, M.P., Biaggi, C., Miescher, S., Vogel. M., Rudolf, M.P. and Stadler, B.M. Molecular basis of crossreactive antibodies. VII. Meeting of the Swiss Immunology Ph.D. Students. Wolfsberg, Switzerland, 20-22March, 1996.Zürcher, M.P., Zürcher, A.W., Rudolf, M.P., Lang, A.B., Stadler, B.M. Protective tetanus toxoid epitopes.SGAI Meeting 1996. St. Gallen, Switzerland, 11.-14. April. 1996.Vogel, M., Lai, L. Curcio-Vonlanthen, R.V., Miescher, S., and Stadler, B.M. Cross reactive anti-tetanus andanti-melittin Fab fragments by phage display after tetanus toxoid immunization. SGAI Meeting 1996. St.Gallen, Switzerland, 11.-14. April. 1996.Horn, M.P., Miescher, S., Vogel, M., Rudolf, M.P., Biaggi, C., and Stadler, B.M. Cross reactive antibodiesagainst tetanus toxoid and the human high-affinity receptor for IgE by phage display. SGAI Meeting 1996. St.Gallen, Switzerland, 11.-14. April. 1996.Rudolf. M.P., Kricek, F., Vogel, M., Miescher, S., and Stadler, B.M. Derivation of a vaccine for atopy based onmimotopes. SGAI Meeting 1996. St. Gallen, Switzerland, 11.-14. April. 1996.Zürcher, A.W., Derer, T., Lang, A.B., and Stadler, B.M. Culture and IgE synthesis of nasal B cells. SGAIMeeting 1996. St. Gallen, Switzerland, 11.-14. April. 1996.Rudolf, M.P., Kricek, F., Vogel, M., Miescher, S., Stadler, B.M. Specific anti-human IgE response bymimotope immunization. New York Academy of Sciences: B Cells and Autoimmunity Meeting. Prague,Czech Republique, 21-25. Mai 1996.Horn, M.P., Miescher, S., Vogel, M., Rudolf, M.P., Biaggi, C., and Stadler, B.M. Isolation of cross reactingantibodies against tetanus toxoid and the human high-affinity receptor for IgE, an autoantigen ofpathphysiological importance. New York Academy of Sciences: B Cells and Autoimmunity Meeting.Prague, Czech Republique, 21-25. Mai 1996.Stadler, B.M., Rudolf, M.P., Zürcher, A.W., Horn, M., Miescher, S., Vogel, M., and Kricek, F. Can activeImmunization redirect an anti-IgE autoimmune response?. Collegium Internationale Allergologicum.Fuschl, Austria 6-11. Sept. 1996.A. Huber, D. Genser, S. Spitzauer, D. Kraft, C. Ebner, B. Stadler and E. Jensen-Jarolim. Does food-specificIgE play a role in Crohn’s disease? Annual Meeting ÖGAI. Vienna, Austria. 1996.Stadler, B.M. Gene therapy in the general context of gene technology. Swiss Tissue Culture SocietyWorkshop „Gene therapy", Egerkingen, Oct. 30., 1996Zürcher, A.W., Rudolf, M.P., Vogel, M., Stadler, B.M. Mimotope-based anti-IgE peptide and DNA vaccines.SGAI/SSAI Meeting, Zürich. Allergologie 20: (2) 74.1997Zimmermann, R., Finger, A., Hohenfeld, U., Klima, I., Gautschi, E., Thalmann, G., Cecchini, M.G., Stdler,B.M, Studer, U., Miescher, S., Ball, R. Gene therapy of prostatic cancer by targeting tumour blood vessels.SGAI/SSAI Meeting 1997, Zürich.Vogel, M.,Miescher,S., Rudolf, M., Stadler, B.M. Evidence of idiotype conservation in mice and men.SGAI/SSAI Meeting, Zürich. Allergologie 20: (2) 90. 1997Horn, M.P., Krebs, S., Vogel, M., Miescher, S., Stadler, B.M. Appearance of cross reactive antibodies againstthe FcRI- chain after tetanus toxoid vaccination. SGAI/SSAI Meeting, Zürich. Allergologie 20: (2) 93.1997.Zürcher, M.P., Zürcher, A.W., Rudolf, M.P., Vogel, M., Lang, A.B., Stadler, B.M. Protective tetanus toxoidepitopes. SGAI/SSAI Meeting, Zürich. Allergologie 20: (2) 91. 1997.Finger, A., Zimmermann, R., Hohenfeld, U., Klima, I., Gautschi, E., Thalmann, G., Cecchini, M.G., Stadler,B.M, Studer, U., Miescher, S., Ball, R. Gene therapy of prostatic carcinoma by targeting tumour bloodvessels. SGAI/SSAI Meeting, Zürich. Allergologie 20: (2) 93. 1997.

C.V.: Beda M. Stadler page 44A-187.A-188.A-189.A-190.A-191.A-192.A-193.A-194.A-195.A-196.A-197.A-198.A-199.A-200.A-201.A-202.A-203.A-204.A-205.A-206.A-207.A-208.Zürcher, A.W., Rudolf. M.P., Vogel. M., Stadler, B.M. Use of mimotpes for immunization and tolerization. IX.Meeting of the Swiss Immunology Ph.D. Students, Wolfsberg 1997.Horn, M.P., Krebs, S., Derer, T., Vogel, M., Miescher, S., Stadler,B.M. Appearance of cross-reactiveantibodies against the FcRI- chain after tetanus toxoid vaccination. IX. Meeting of the SwissImmunology Ph.D. Students, Wolfsberg 1997.Zimmermann, R., Finger, A., Hohenfeld, U., Klima,I., Gautschi, E., Thalmann, G.,Cecchini, M.G., Stadler,B.,Studer, U., Miescher, S., Ball, R. Gene therapy of prostate carcinoma by targeting tumour blood vessels. IX.Meeting of the Swiss Immunology Ph.D. Students, Wolfsberg 1997.Horn, M.P., Krebs, S., Derer, T., Vogel. M., Miescher, S., Stadler,B.M. Appearance of cross-reactiveantibodies against the FcRI- chain after tetanus toxoid vaccination. 13 th European Immunology Meeting,Amsterdam, 1997.Zürcher, M.P., Vogel. M., Zürcher, A.W., Rudolf, M.P., Kaufmann, H., Lang, A.B., Miescher, S.M., Stadler,B.M. Protective tetanus toxoid epitopes. 13 th European Immunology Meeting, Amsterdam, 1997.Kricek, F., Ruf, C., Rudolf, M.P., Stadler, B.M., Effenberger, F. and Reuschel, R. IgE-related peptidemimotopes: Basic structures for anti-allergy vaccine developement. 13 th European Immunology Meeting,Amsterdam, 1997.Kricek, F., Ruf, C., Nechanski, A., Pursch, E., Rudolf, M.P., and Stadler, B.M. Is IgE-FceRI binding andinduction of target cell triggering a process involving different Fce domains and conformationalrearrangement? 13 th European Immunology Meeting, Amsterdam, 1997.Pachlopnik, J.M., Stämpfli, M., Äbischer, I., Rudolf, M.P., Miescher, S., and Stadler, B.M. Different IgEconformations and IgE measurements. SGAI/SSAI Meeting, Zürich. Allergologie 20: (2) 87. 1997.Thalmann, G., Ball, R. Stadler, B.M. and Studer U.E. Gentherapie der Neurovaskularistion von Tumoren.Schweiz. Ges. für Urologie, Jahresversammlung. Luzern, 1997Horn, M., Gerster, T., Vogel, M., Miescher, S., Kricek, F., Kinet, J-P., and Stadler, B.M. Autoantibodiesagainst both native and denatured FcRI--chain in human serum. SGAI Kongress 1998,Jahresversammlung Genf, 1998.Zürcher, A.W., Vogel, M., Rudolf, M.P., Kricek, F., and Stadler, B.M. Oral immunization with bacteriophages.SGAI Kongress 1998, Jahresversammlung Genf, 1998.Zürcher, A.P., Vogel, M., Zürcher,A.W., Kaufmann, H., Lang, A.B., Miescher, S.M., and Stadler, B.M.Protective tetanus toxoid epitopes. SGAI Kongress 1998, Jahresversammlung Genf, 1998.Vogel., M., Miescher, S.M., Rudolf, M.P., Kricek, F., and Stadler, B.M. Epitope mimicry by anti-idiotypicantibodies. SGAI Kongress 1998, Jahresversammlung Genf, 1998.Blumenthal, N.K., Vogel, M., Gerritsen H, Miescher, S.M., Furlan, M., Stadler, B.M. Autoantibodies as acausative agent of TTP? SGAI Kongress 1998, Jahresversammlung Genf, 1998.Cecchini M.G., Wetterwald A., Gautschi E., Stadler B.M., Studer U.E. and G.N. Thalmann: Isolation ofbacteriophage-displayed peptides that bind to human renal carcinoma endothelial cells ex vivo. ThirteenthCongress of the European Society for Urological Oncology and Endocrinology, Innsbruck, Austria,1998.Stadler, B.M. Mehr Allergien durch Gentechnik? Strategien zur Risikominimierung. 2. ISEM Jahrestagung1998, Giessen, Umweltmedizin in Forschung und Praxis . 3: 195. 1998.Escher, R., Wie, Y., Amstutz, P., Miescher, S.M., Vogel, M., Stadler, B.M., Berchtold P. Recombinant antigpIIB/IIIAautoantibodies from different normal donors share high homologies. American Society ofHematology Meeting, Miami Beach, Florida. 1998Vogel, M., Miescher, S., Kuhn, S., Stadler B.M. Un anticorps recombinant anti-idiotypique mimotope de l’IgE.Congrès sur les banques d’expression à la surface des phage, Les Pensières, Veyrier du Lac, 1998.Pachlopnik JM, Stämpfli MR, Aebischer I, Rudolf MP, Miescher SM, Stadler BM. Antigen interaction and heatinactivation expose new epitopes on human IgE. Tag der klinischen Forschung, Bern 1998Pachlopnik JM, Horn MP, Vogel M., Miescher SM, and. Stadler BM. Anti-FcRI antibodies used for isolationof anti-idiotypic Fabs and mimotopes in order to produce tools for active immunization. X. Meeting of theswiss immunology PH.D. students at Schloss Wolfsberg, 1998Finger, A.N., Wetterwald, A., Gautschi, E., Hohenfled, U., Thalmann, G.N., Miescher, S., Stadler, B.M.,Cecchini, M.G. Identification of bone marrow specific peptide ligands by phage petide library panning in vivo.Tag der Klinischen Forschung, Bern, 5.11.1998.Vogel, M., Miescher, S., Kuhn, S., Stadler B.M. Anti-Id vaccine to induce an anti-IgE response. PhageDisplay Technology Conference, Cardiff, 1998.

C.V.: Beda M. Stadler page 45A-209.A-210.A-211.A-212.A-213.A-214.A-215.Cecchini, M.G., Wetterwald, A., Thalmann, G., Finger, A.N., Gautschi, E., Hohenfeld, U., Bisoffi, M.,Miescher, S. Stadler, B.M. Identification of organ specific and tumor specific endothelial molecules by phagepeptide library panning in vivo and ex vivo. Tag der Klinischen Forschung, Bern, 5.11.1998.Miescher, S., Vogel, M., Kuhn, S., Stadler B.M., Fisch, I. Utilisation de globules rouges traitées à la bromélainpour isoler des anticorps recombinants anti-Rhésus D montrant une spécificité pour l’épitope rhésus DVI.Congrès sur les banques d’expression à la surface des phage, Les Pensières, Veyrier du Lac, 1998.Cecchini, M.G., Gautschi, E., Wetterwald,A., Thalmann, G.N., Miescher, S., Vogel, M. Stadler, B.M. Randompeptide phage displayed library panning in vivo: A method for the identification of bone marrow specificligands. Tag der Klinischen Forschung, Bern, 5.11.1998.Finger, A.N., Wetterwald, A., Gautschi, E., Hohenfeld, U., Thalmann, G.N., Miescher, S., Stadler, B.M.,Cecchini, M.G. Identification of bone marrow endothelial specific molecules by phage peptide library panningin vivo. Meeting of the swiss immunology PH.D. students at Schloss Wolfsberg, 1998.Cecchini, M.G., Wetterwald, A., Gautschi, E., Stadler, B.M., Studer, U.E., Thalmann, G.N. Isolation of phagedisplayedpeptides that bind to human renal carcinoma endothelial cells ex vivo. Tag der KlinischenForschung, Bern, 5.11.1998.Pachlopnik, J.M., Horn, M.P., Miescher, S.M., Stadler, B.M. Epitope specificity of anti- FcRI-antibodiesdetermines the autoimmune nature of chronic urticaria. SGAI Kongress 1999, InterlakenVogel, M. Kuhn, S., Miescher, S.M., Stadler, B.M. Anti-Id vaccine to induce an anti-IgE response. SGAIKongress 1999, InterlakenA-216.A-217.A-218.Horn, M.P., Vogel, M., Stadler, B.M., Miescher, S.M. Natural anti-FcR1 antibodies may serve as parentalantibodies for an anti-tetanus toxoid response. SGAI Kongress 1999, InterlakenFinger, A.N., A. Wetterwald, E. Gautschi, U. Hohenfeld, M. Bisoffi, G.N. Thalmann, S. Miescher, B.M. Stadlerand M.G. Cecchini (Bern): Identification of bone marrow specific ligands by phage peptide library panning invivo. SGAI Kongress 1999, InterlakenZuercher, A.W., S.M. Miescher, M. Vogel, M.P. Rudolf, M.B. Stadler and B.M. Stadler Oral anti-IgEimmunization with epitope-displaying phage: Evidence for transient colonization.. SGAI Kongress 1999,InterlakenA-219. Stadler, M.B., M.P. Horn, M. Vogel, M.P. Zürcher, A.W. Zürcher, A.B. Lang, S.M. Miescher and B.M. Stadler :Diphtheria toxin epitopes for synthetic vaccine. SGAI Kongress 1999, InterlakenA-220.A-221.A-222.A-223.A-224.A-225.A-226.A-227.A-228.A-229.Cecchini MG, Gautschi E, Wetterwald A, Finger AN, Hohenfeld U, Bisoffi M, Thalmann GN, Gimmi C, andStadler BM. Structural requirements of synthetic bone marrow targeting peptides (BMTPs) for binding to themarrow endothelium. NFP37 “Somatic Gene Therapy” Third Annual Meeting, Fribourg, October 7-8,1999.Cecchini MG, Gautschi E, Wetterwald A, Finger AN, Hohenfeld U, Bisoffi M, Thalmann GN, Gimmi C andStadler BM. Phage library panning in vivo as a method for the identification of ligands specific for the tumorvasculature. NFP37 “Somatic Gene Therapy” Third Annual Meeting, Fribourg, October 7-8, 1999.Pachlopnik JM, Horn MP, Miescher SM, and Stadler BM. Auto-antibody specificity and the pathogenesis ofautoimmune urticaria. XI. Meeting of the swiss immunology PH.D. students at Schloss Wolfsberg, 1999Christine Thurnheer, Adrian W. Zuercher, Sylvia M. Miescher, Michael P. Rudolf, Monique Vogel, and BedaM. Stadler. A Specificity for IgE-ND. SGAI Kongress 1999, InterlakenZürcher, M.P., M. Vogel, A.W. Zürcher, A.B. Lang, S.M. Miescher and B.M. Stadler . Tetanus VaccineGeneration via Antibody Selection in vitro SGAI Kongress 1999, InterlakenHorn, M.P., M. Vogel, B.M. Stadler, and S.M. Miescher. Are natural anti-FceRIa autoantibodies the parentalantibodies for TT specificity?. XI. Meeting of the Swiss Immunology Ph.D. Students. Wolfsberg. 1999Horn, M.P., M. Vogel, B.M. Stadler, and S.M. Miescher. Molecular characterization of natural anti-FcRIautoantibodies using phage display. Cambridge Healthtech Institute’s drug discovery & developement series.Phage display: Novel therapeutics and diagnostics. Cambridge, MA. USA 1999Zürcher, M.P., M. Vogel, A.W. Zürcher, A.B. Lang, S.M. Miescher and B.M. Stadler TETANUS VACCINEGENERATION VIA ANTIBODY SELECTION Meeting of the Swiss Immunology Ph.D. Students.Wolfsberg. 1999Stadler, M.B., Horn, M.P., Vogel M., Zürcher M.P., Zürcher A.W., Lang A.B., Miescher S.M. and Stadler B.M.DIPHTHERIA TOXIN: IS THE MOST PROTECTIVE EPITOPE MIMICKING SELF? Meeting of the SwissImmunology Ph.D. Students. Wolfsberg. 1999Finger, A.N., Wetterwald, A., Gautschi, E., Hohenfeld, U., Bisoffi, M., Thalmann, G.N., Miescher, S., Stadler,B.M. Cecchini, M.G. Identification of bone marrow specific peptide ligands by random peptide phagedisplayed library panning in vivo. Keystone Symposia, January, 14 - January, 20, 1999.

C.V.: Beda M. Stadler page 46A-230.A-231.A-232.A-233.A-234.A-235.A-236.A-237.A-238.A-239.A-240.A-241.A-242.A-243.A-244.A-245.A-246.A-247.A-248.A-249.Pachlopnik, J.M., Horn, M.P., Vogel., M., Miescher, S.M., Stadler, B.M.. Comparison of autoantibodyrepertoire of healthy donors and chronic urticaria patients. Jahresversammlung der SchweizerischenGesellschaft für Allergologie und Immunologie 2000. Basel, Allergologie 23: 133. 2000.Stadler, M.B., Horn, M.P., Vogel., M., Zürcher, M.P., Zürcher, A.W., Lang, A.B., Miescher, S.M., Stadler, B.M.Isolation of protective diphtheria epitopes. Jahresversammlung der Schweizerischen Gesellschaft fürAllergologie und Immunologie 2000. Basel, Allergologie 23: 139. 2000.Zürcher, M.P., Vogel, M., Tarantino, I., Zürcher, A.W., Hofmann, A.E., Lang, A.B., Rose K., Miescher, S.M.,Stadler, B.M. Repetitive epitopes on tetanus toxin. Jahresversammlung der Schweizerischen Gesellschaft fürAllergologie und Immunologie 2000. Basel, Allergologie 23: 141. 2000.Bisoffi Marco, Finger Anita N., Wetterwald Antoinette, Hohenfeld Ulrike, Gautschi Elsbeth, Stadler Beda M.,Cecchini Marco G., Studer Urs E., and Thalmann George N. IDENTIFICATION OF BONE MARROWTARGETING PEPTIDE (BMTP) RECEPTORS. N° 181. Homepage: l'Association pour la Recherche surles Tumeurs de la Prostate http://www.artp.org/abstracts/ACT_nr181_P.htmHorn, M.P., Pachlopnik, J.M., Vogel., M., Stadler, B.M., Miescher, S.M. Human anti-Fc RI antibodies areconditional autoantibodies. Jahresversammlung der Schweizerischen Gesellschaft für Allergologie undImmunologie 2000. Basel, Allergologie 23: 148. 2000.Vogel, S., Miescher, S., Kuhn, S., Stadler, B.M. Recombinant anti-idiotypic antibodies that mimic selfepitopesof human IgE. Jahresversammlung der Schweizerischen Gesellschaft für Allergologie undImmunologie 2000. Basel, Allergologie 23: 153. 2000.Stadler, B.M., S.M. Miescher, M.P. Horn, J.M. Pachlopnik, M.B. Stadler, F. Kricek, M. Vogel. Allergicmanifestations as the results of a conditional autoimmune response? CIA Meeting. Japan. 2000.Stadler, M.B., M.P. Horn, M. Vogel, M.P. Zürcher, A.W. Zürcher, A.B. Lang, S.M. Miescher, and B.M. Stadler.Isolation of active and passive diphtheria vaccines. XII. Meeting of the Swiss Immunology Ph.D. Students.Wolfsberg. 2000.Pachlopnik. J.M., M.P. Horn, M. Vogel, S.M. Miescher, and B.M. Stadler.. Anti-IgE-receptor Antibodies inChronic Idiopathic Urticaria. XII. Meeting of the Swiss Immunology Ph.D. Students. Wolfsberg. 2000.Stadler B.M., Vogel M., Stadler M., Miescher S., and Kricek F. Mimotopes and Anti-Idiotypic Antibodies asVaccines in the Context of Self-Recognition. World congress on Vaccines, Liège, Belgium. 2000Schmid, M.C., Bisoffi, M., Wetterwald, A., Gautschi, E., Thalmann, G.N., Stadler, B.M., Mitola, S., Bussolino,F., and Cecchini, M.G. Gene expression profiling of tumor-derived endothelial cells. Tag der KlinischenForschung, Bern, November 22, 2000.Ganglberger, E., Sponer, B., Wiedermann, U., Schöll, I., Vermes, M., Baumann, S., Stadler, B.M., Scheiner,O., and Jensen-Jarolim, E. Fusion proteins of IgE mimotopes with albumin binding protein for diagnosis andtherapy of birch pollen allergy. Annual Meeting Austrian Society of Allergology and Immunology (ÖGAI),Vienna, November, 2000.Ganglberger, E., Sponer, B., Wiedermann, U., Schöll, I., Vermes, M., Baumann, S., Stadler, B.M., Scheiner,O., and Jensen-Jarolim, E. Immunoglobulin E mimotopes fused to a streptococcal albumin binding proteinare promising candidates for diagnosis and therapy of Type I allergy. 57 th Annual Meeting AmericanAcademy of Allergy and Immunology (AAAAI), New Orleans, March, 2001.Fux M., Stadler M. B., Vogel M., Lang A. B., Miescher S. M.1 and Stadler B. M. GENERATION OFRECOMBINANT ANTI-DIPHTHERIA NEUTRALIZING ANTI-BODIES. Annual Meeting SSAI 2001Lausanne. 2001.de Sá J. , Vogel M. , Lang A.B. and Stadler B.M. Mimicry of Carbohydrate Structures from Pseudomonasaeruginosa by anti-idiotypic antibodies. Annual Meeting SSAI. Lausanne. 2001.Dahinden M, Pachlopnik JM, Horn MP, Vogel M, Stadler BM, and Miescher SM1. Sequence comparison ofnatural anti-FcRIa autoantibodies isolated from healthy donors versus chronic idiopathic urticaria (CIU)patients reveals a similar, highly restricted repertoire. Annual Meeting SSAI. Lausanne. 2001.Lorenz Scheppler, Monique Vogel, Jacques-Edouard Germond, Sylvia M. Miescher and Beda M. Stadler.Surface display of a Single-Chain Fv Antibody on Lactobacillus johnsonii (La1) for Oral Vaccination. AnnualMeeting SSAI. Lausanne. 2001.Vogel M., Kuhn S, Miescher S. and Stadler B.M. HUMANISATION OF MURINE ANTI-HUMAN IgEANTIBODY BY PHAGE DISPLAY. Annual Meeting SSAI. Lausanne. 2001.Lorenz Scheppler, Adrian Zürcher, Jacques-Edouard Germond, Monique Vogel and Beda M. Stadler. OralVaccination of Mice with Recombinant Lactobacillus johnsonii (La1). Annual PhD Meeting. Wolfsberg. 2001.Finger, A.N., Bisoffi, M., Wetterwald, A., Gautschi, E., Hohenfeld, Klima, I., U., Thalmann, Stadler, B.M., andCecchini, M.G. A novel strategy for the identification by phage panning in vivo of ligands specific for cells inthe extravascular space. BIOLOGICAL THERAPY OF CANCER, 6th International Symposium, Munich. Sept12-15, 2001.

C.V.: Beda M. Stadler page 47A-250.A-251.A-252.Arnold, D., Aufdenblatten, E., Blatter, R., Vogel, M., Seiner, B., Schawaller, M., Meriqux, Y., Stadler,B.M. andMiescher, S.M. Recombinant human antibodies against platelet alloantigen HPA-5b for diagnostics and aspotential therapeutic agent. Annual Meeting SSAI 2002 Lugano, Swiss Med WKLY 132, Suppl. 129, 32,2002.de Sá, J., Vogel, M., Miescher,S., Horn, M., Lang,A.B., Stadler,B.M. Mimicry of carbohydrate structures frompseudomonas aeruginosa by anti-idiotypic antibodies. Annual Meeting SSAI 2002 Lugano, Swiss MedWKLY 132, Suppl. 129, 29, 2002.Fux, M., Bobrzynski, T., Vogel, M., Stadler, B.M., an Miescher, S.M. the light chain of autoantibodies againstthe IgE receptor defines their biological activity. Annual Meeting SSAI 2002 Lugano, Swiss Med WKLY 132,Suppl. 129, 44, 2002.A-253. Stadler, M.B., Stadler, B.M. Predicting allergenicity from protein primary structure. Annual Meeting SSAI 2002Lugano, Swiss Med WKLY 132, Suppl. 129, 44, 2002.A-254.A-255.A-256.A-257.A-258.A-259.A-260.A-261.A-262.A-263.A-264.A-265.A-266.A-267.A-268.Vogel, M., Gautschi, E., Kricek F., Miescher,S.M. and Stadler,B.M. Humanisation of murine anti-human IgEantibody by guided selection. Annual Meeting SSAI 2002 Lugano, Swiss Med WKLY 132, Suppl. 129, 44,2002.Scheppler, L., Marti, P., Vogel, M., Germond, J.-E., Fritsche, R., Miescher,S.M., Stadler, B.M. Expression ofan anti-idiotpyic antibody on the surface of recombinsant lactobacillus johnsonii. Annual Meeting SSAI 2002Lugano, Swiss Med WKLY 132, Suppl. 129, 28, 2002Scheppler, L., Marti, M., Vogel, M. Germond, J.-E., Miescher, M., Stadler, B.M. Linker sequence exchange toimprove expression of single chain fragment variable in Lactobacillus johnsonii. Swiss Med WKLY 133,Suppl. 135, 31, 2003.Fux, M., Bobrzynski, T., Vogel, M., Stadler, B.M. Miescher, S.M. Detection of a natural autoantibody heavychain sequence directed against the (alpha)-chain of the Fc(epsilon)RI in healthy donors and chronic urticariapatients. Swiss Med WKLY 133, Suppl. 135, 34, 2003.de Sá, J., Vogel, M., Miescher, S., Horn, M., Lang. A.B., Stadler, B.M. Aunti-idiotypic mimicry of carbohydrateantigens of Pseudomonas aeruginosa. Swiss Med WKLY 133, Suppl. 135, 31, 2003.Müller, L., Vogel, M., Stadler, M.B., Christen, P., Stadler, B.M. Can wasp allergen induce an autoimmuneresponse? Swiss Med WKLY 134, Suppl. 140, 5, 2004.Bobrzynski, T., Fux, M., Vogel, M., Stadler, M.B., Stadler, B.M., Miescher, S.M. Evidence for a commonepitope on the human IgE receptor type I defined by human natural autoantibodies. Swiss Med WKLY 134,Suppl. 140, 5, 2004.Stadler, M.B., Arnold, D., Frieden, S., Luginbühl, S., Stadler, B.M. Bioinformatic analysis of autoantigens.Swiss Med WKLY 134, Suppl. 140, 7, 2004.Fux, M., Vogel, M., Gautschi, E., Stadler, B.M., Miescher, S.M. Gene copy analysis of anti-FcRI heavychain sequence in chronic urticaria patients and healthy donors. Swiss Med WKLY 134, Suppl. 140, 7, 2004.Truffer, R., Stadler, M.B., Stadler, B.M. A tool for the evaluation of clinical allergen cross-reactions. SwissMed WKLY 134, Suppl. 140, 9, 2004.Marti, P., Stadler, M.B., Vogel. M., Scheppler, L., Germond, J.-E., Stadler, B.M An allergen motif sequenceas a consensus for related allergens. Swiss Med WKLY 134, Suppl. 140, 11, 2004.Marti P., Truffer R., Vogel M., Stadler M.B., Crameri R., Stadler B. Allergen motifs as representatives forcross-reactive allergens. Ann. Meeting, Swiss Soc. Allergol. Immunol., Berne, March 2004Vogel, M., Stadler, M.B., Gautschi, E., Stadler, B.M. Cross-reactive allergic and autoantigenic epitopes: a linkbetween allergy and autoimmunity? Swiss Med WKLY 134, Suppl. 140, 13, 2004.de Sá, J., Stadler, B.M Naturally occurring antibodies against erypthropoietin. Swiss Med WKLY 134, Suppl.140, 17, 2004.Wallmann J, Hantusch B, Knittelfelder R, Szalai K, Untersmayr E, Riemer A 1, Vogel M, Stadler B , Boltz-Nitulescu G, Jensen-Jarolim E. ANTI-IDIOTYPIC FAB MIMOTOPES PRESENT INTERNAL IMAGES OFMAJOR GRASS POLLEN ALLERGEN PHL P 5. Annual Meeting of the ÖGAI. 2005A-269. Julia Wallmann , Brigitte Hantusch, Regina Knittelfelder, Krisztina Szalai, Eva Untersmayr, Angelika B.Riemer, Monique Vogel, Beda M. Stadler, George Boltz-Nitulescu, Erika Jensen-Jarolim. Grass-pollenallergic patients harbor anti-idiotypic antibodies mimicking natural Phl p 5 epitopes. 35th Annual EuropeanSociety for Dermatological Research Meeting. (22.-24.Sept. 2005, Tübingen, Deutschland) Vortrag undPoster.The Journal of Investigative Dermatology 2005, 125(No.3, supplement1): A51, Abstract 298.A-270.Wallmann J, Hantusch B, Knittelfelder R, Szalai K, Untersmayr E, Epstein M, Vogel M, Stadler B, Boltz-Nitulescu G, Jensen-Jarolim E. Recombinant anti-idiotypic Fab antibodies against allergen-specific IgE: toolsto analyse memory phenomena via molecular mimicry? EAACI Congress. Vienna. 2006

C.V.: Beda M. Stadler page 48A-271.A-272.Wallmann J, Hantusch B, Knittelfelder R, Szalai K, Untersmayr E, Riemer A, Vogel M, Stadler B, Boltz-Nitulescu G, Jensen-Jarolim. ANTI-IDIOTYPIC FAB MIMOTOPES PRESENT INTERNAL IMAGES OFMAJOR GRASS POLLEN ALLERGEN PHL P 5. vfwf Universitätsvorlesung. 31.5.2006Wallmann J, Hantusch B, Knittelfelder R, Szalai K, Untersmayr E, Epstein M, Vogel M, Stadler B, Boltz-Nitulescu G, Jensen-Jarolim E. RECOMBINANT ANTI-IDIOTYPIC FAB ANTIBODIES AGAINSTALLERGEN-SPECIFIC IGE: TOOLS TO ANALYSE MEMORY RESPONSE INDUCTION VIA MOLECULARMIMICRY? 7th EFIS Tatra Immunology Conference, 24-28.Juni 2006.